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ABSTRACT 
The cornea is the optically transparent tissue through which light first enters the eye. 
Together with the lens, the cornea bends incident light to focus it onto the photosensitive retina. 
Corneal fibrosis occurs in response to ocular trauma and infection and, by reducing corneal 
transparency, can impair or completely diminish this function, leading to vision impairment and 
blindness. Millions of people around the globe suffer from corneal blindness as a result of injury 
and infection. Fortunately, topical antibiotics and immunosuppressants help to prevent scars 
from forming. Should a scar develop, corneal transplant is a generally successful procedure that 
can restore sight to these patients. There are, however, drawbacks and limitations to the 
procedure in that immunological rejection of the donor graft and a limited supply of donor tissue 
prevent many patients from sustaining or receiving this treatment. The body of work presented 
here investigates stem cells as an alternative treatment for vision-impairing fibrotic wounds in 
the corneal stroma. First, I show that human embryonic stem cells are capable of differentiating 
to cells with a corneal keratocyte phenotype, a study that may lead to the development of a 
source of cells to repair damaged corneal tissue. I then show that a population of corneal stromal 
stem cells can be isolated in a biopsy-like procedure and prevent fibrotic wound healing in the 
mouse, presenting an autologous source of cells to treat corneal scars. Finally, I investigate a 
potential mechanism by which these stem cells prevent fibrotic wound healing via 
STEM CELLS FOR THE TREATMENT OF CORNEAL FIBROSIS 
Andrew J. Hertsenberg, PhD 
University of Pittsburgh, 2015
 
 v 
immunomodulation and the suppression of neutrophil infiltration to the wound bed. This work 
moves toward the development of an alternative to corneal transplantation that will bridge the 
gap between the supply and demand of donor tissue and provide a treatment option with a 
significantly reduced risk of failure due to rejection.  
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1.0  INTRODUCTION 
The cornea is the first tissue through which light enters the eye. It is responsible for two-thirds of 
the eye’s refractive power and is a barrier to environmental insults, trauma from foreign bodies, 
and infection. As such, it is imperative that its structural and functional integrity be maintained. 
The three layers of the cornea - the epithelium, stroma, and endothelium - function together to 
refract light to the photosensitive retina at the back of the eye. 
Millions of people around the globe suffer from vision impairment and blindness due to 
corneal opacities 3,4. Vision loss dramatically changes an individual’s way of living and quality 
of life. Fortunately, individuals living in parts of the world with reliable access to healthcare 
rarely develop scarring after injury/infection due to rapid treatment and regular follow-ups with 
an ophthalmologist. In the event that an individual does develop vision-impairing opacity, 
corneal transplant is a common procedure with a relatively high success rate. Unfortunately, 
however, worldwide demand for donor tissue vastly outnumbers available grafts and 
immunological rejection poses a threat to graft survival. 
The goal of this collection of work was to demonstrate that stem cells, both allogeneic 
and autologous in source, represent alternative therapies for the treatment of corneal fibrosis. To 
achieve this goal, my colleagues and I have taken cues from corneal development to generate 
keratocyte-like cells from human embryonic stem cells and worked with clinicians to develop 
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methods for isolating corneal stem cells in a biopsy treatment to one day use as an autologous 
method for the treatment of corneal fibrosis. 
The human cornea develops from surface ectoderm (corneal epithelium) and the neural 
crest (corneal stroma and endothelium) starting at 6 weeks gestation and contains all three 
cellular layers by 11 weeks 5. The developmental process involves cellular contributions from 
both the surface ectoderm and neural crest and will be described further in Section 1.1. In most 
mammals the cornea develops transparency shortly after birth shortly after eyelid opening.  
Embryonic development informs the field of regenerative medicine and lends support to 
hypotheses that aim to differentiate pluripotent stem cells for use in cell therapy and tissue 
engineering. Indeed, embryonic stem cells are often differentiated in vitro toward a desired cell 
fate by mimicking developmental processes in normal human development, as is demonstrated 
here in differentiating human embryonic stem cells to a corneal keratocyte-like cell (Chapter 2).  
Moreover, stem/progenitor cells have been identified in all three cellular layers of the 
cornea (Section 1.2), potentially providing a source of cells for autologous cell therapy and 
undoubtedly enhancing out understanding of corneal cell biology and wound healing. In Chapter 
3, I present data demonstrating that a population of corneal stromal stem cells can be isolated in a 
biopsy-like procedure and prevent fibrotic wound healing in the mouse. Finally, in Chapter 4, I 
suggest a mechanism by which these stem cells prevent fibrosis in immunomodulation via their 
interaction with infiltrating neutrophils to the wound bed. 
Vision is often taken for granted among the sighted population but is perhaps the sense 
most vulnerable to impairment and destruction by environmental factors. The current treatment 
options are generally successful but there is a need for greater demand and higher success rate 
that must be met – here I suggest that stem cells may lead to such an alternative treatment. 
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1.1 THE CORNEA 
1.1.1 Corneal Development 
Mammalian eye development begins with the formation of the optic vesicle, the morphological 
result of the evagination of the forebrain. The optic vesicle eventually comes into close 
proximity with the surface ectoderm wherein inductive signals between the two layers are 
thought to play a critical role in further ocular development (Figure 1A) 6. Specifically, the lens 
placode forms from a region of surface ectoderm that then invaginates to form the lens vesicle 
(Figure 1B). Importantly, this invagination leads to the formation of the corneal epithelium from 
the remaining surface ectoderm. 
Shortly after the formation of the lens vesicle, the corneal endothelium and stroma form 
from migrating neural crest cells (Figure 1C). It has been demonstrated in the avian cornea that 
the formation of the stroma is regulated by chemotactic signals secreted by the lens, with neural 
crest cells first resting in the periocular mesenchyme (adjacent to the lens) before migrating into 
the presumptive stroma between the lens and epithelium 7-9. At birth, the mammalian cornea is 
not transparent but transluscent, but becomes transparent with deturgescense and the expression 
of corneal crystalline proteins 10,11. In chapter 2, insights gained from corneal development are 
used to induce keratocyte differentiation in human embryonic stem cells using a neural crest 
intermediary step. 
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1.1.2 Corneal Anatomy and Physiology 
The cornea is composed of three cellular layers: the corneal epithelium at the anterior, the 
corneal endothelium at the posterior, and the stroma sandwiched in between (Figure 2). Two 
basement membranes, the anterior limiting lamina (Bowman’s membrane) and posterior limiting 
lamina (Descemet’s membrane) separate the epithelium and corneal endothelium, respectively, 
from the corneal stroma. While the corneal stroma comprises the bulk of the corneal structure, 
each layer must function properly in order to maintain transparency required for vision.  
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Figure 1 Corneal Development 
A)Optic Vesicle and Surface Ectoderm interact to initiate the Lens Placode. 
B) The Lens Placode (red) results in an invagination of the surface ectoderm 
and presumptive retina (green). 
C) Migrating neural crest cells (blue circles) invade the space between the 
presumptive corneal epithelium and lens. 
D) The cornea, lens, and retina take shape. 
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1.1.2.1 The Corneal Epithelium. Corneal epithelium is regularly renewed due to continuous 
environmental insults and desquamation. A steady movement of epithelial cells from the 
peripheral limbal region of the cornea (an anatomical marker between the cornea and sclera) 
toward the central cornea has been documented in a number of studies 12-15. For this reason, 
corneal abrasions limited to the epithelium are generally well tolerated (though painful) and do 
not lead to vision impairment or blindness. However, in rare instances, corneal epithelial 
abrasions do not heal properly and lead to corneal edema and irregularity of the epithelial 
surface, both of which cause vision impairment. Normally smooth, a rough epithelial surface 
leads to impairment in light refraction by the cornea that results in visual impairment 16,17. 
Fortunately, limbal epithelial cell transplant may restore epithelial integrity and the smooth 
surface necessary for transparency. 
Figure 2 The Cornea 
The three layers of the cornea: epithelium (shown: 
epithelial cells), stroma (shown: keratocytes), and endothelium 
(shown: corneal endothelial cells). 
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 Immediately posterior to the corneal epithelium is the Anterior Limiting Lamina, or 
Bowman’s Membrane (BM). Approximately 12 μm thick, BM is composed of collagen fibrils 
that contribute to a smooth anterior surface and merge posteriorly with stromal collagen 18. There 
are multiple hypotheses suggesting a function for BM, namely that it serves as a protective 
barrier to the stroma, a biological barrier preventing infectious agent infiltration to the stroma, 
and as a facilitator of rapid stromal wound healing after corneal injury 19,20. Importantly, BM 
does not regenerate after wounding and may contribute to scar formation, though more studies 
are needed to demonstrate its function in wound healing 21. 
1.1.2.2 The Corneal Stroma. The corneal stroma is a tough, collagenous tissue that comprises 
about 90% of the cornea. Corneal collagen is arranged in sheets of fibrils called lamellae that are 
arranged orthogonally throughout the stroma. The precise spacing and arrangement of the fibrils 
and lamellae is essential to stromal transparency 22. The stroma is sparsely populated with 
quiescent, mesenchymal cells, called keratocytes, which are responsible for collagen production 
and turnover. The quiescent stroma is avascular and optically transparent, ensuring visual acuity. 
 The stroma is composed of tightly packed and regularly spaced collagen, primarily types  
I and V 23. Due to the physiological requirement that the cornea be transparent for acute vision 
and the unique arrangement of corneal collagens not seen in opaque collagenous tissues in the 
Figure 3 The Corneal Epithelium 
 7 
body (e.g. skin), investigators concluded that there may be a role for collagen arrangement in 
stromal transparency 24,25. Indeed, the collagen fibrils and their interactions with 
proteoglycans/glycosaminoglycans in the stroma, as well as the arrangement of fibers into 
lamellae are key to stromal transparency 26. Collagen fibrils are connected and their growth and 
arrangement thought to be regulated by proteoglycans, heavily glycosylated proteins with 
covalently attached glycosaminoglycans (Figure 4)27-29. Since collagen arrangement and fibril 
spacing is thought to be important to stromal transparency, it stands to reason that abnormalities 
in stromal ECM and collagen arrangement would lead to corneal opacity. Fibrotic wound healing 
after injury often leads to the deposition of extracellular matrix that lacks this organization, 
preventing stromal transparency. 
  
 
Upon wounding, the normally quiescent keratocytes adjacent to the damaged area 
become mitotically active fibroblasts and migrate to the healing area, subsequently 
differentiating to myofibroblasts. These cells are responsible for the production of matrix 
A B 
Figure 4 Collagen in the Corneal Stroma 
Transmission Electron Microscopy (TEM) images of the corneal stroma. A) TEM of the corneal stroma 
reveals orthoganlly organized collagen lamellae; K, Keratocyte. B) TEM at the lamellar border shows fibril 
bands longitudinally and in cross section. Arrowheads show proteoglycans. Scale bar: 100 nm. 
Reprinted with permission: (A) Ambekar et. al.1 (B) Lewis et. al.2 
 
 8 
metalloproteinases and of fibrotic extracellular matrix components that contribute to light scatter 
by stromal scarring 30-34. Fibronectin, tenascin-C, laminin, collagens III, IV, VII, and hyaluronan 
production is markedly upregulated within 10 days after wounding, contributing to disorganized, 
opaque extracellular matrix inconsistent with transparency 35. 
Collagen turnover in the healing cornea eventually results in normal collagen production 
and, with time, the newly synthesized lamellae join with the lamellae at the wound edge 36. It has 
been shown in rabbits that in 12-18 months this remodeling process results in transparent stromal 
tissue from opaque scar tissue 37,38. Unfortunately, scar resolution in humans varies enormously 
between individuals and causes such decline in quality of life that corneal transplant is 
recommended. 
1.1.2.3 The Corneal Endothelium. Immediately subjacent to the corneal stroma lies the 
posterior limiting lamina, or Descemet’s Membrane (DM), and the corneal endothelium. 
Descemet’s Membrane consists of collagens type IV and VIII and is 8-10 μm thick in adults 39,40. 
Damaged DM often requires transplant surgery, as the membrane is required for corneal 
Figure 5 The Corneal Endothelial Pump Function 
The corneal endothelial allows passive transport of water molecules into the stroma and 
actively transports glucose into the stroma. To maintain corneal deturgescence, water is 
actively transported from the stroma into the anterior chamber via a chemical gradient (e.g. 
by transporting bicarbonate into the anterior chamber and allowing water to follow). 
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endothelial cell function, which is critical to corneal transparency. 
The corneal endothelium (CE) is a single layer of epithelial cells that lie on the DM 
facing the anterior chamber. This layer plays a critical role in stromal transparency by helping to 
maintain corneal deturgescence. Corneal endothelial cells have a pump function that effluxes 
water from the stroma via a chemical gradient made of solutes like sodium bicarbonate (Figure 
5). Because water is able to passively diffuse into the stroma from the anterior chamber, the 
steady pump function is necessary to keep the stroma in a relative state of dehydration that 
maintains collagen arrangement and spacing in so as to maintain transparency. Additionally, the 
CE transports nutrients such as glucose across DM and into the stroma for cell metabolism and 
tissue function. 
1.2 STEM CELLS IN THE CORNEA 
1.2.1 Limbal Epithelial Stem Cells 
A remarkably important tissue for both corneal and ocular health, the corneal epithelium (with 
the tear film) is the first line of defense against foreign bodies and pathogenic microorganisms. 
The corneal epithelium is constantly undergoing desquamation and regeneration as a normal 
physiological process. It is imperative that the corneal epithelium remains intact to protect the 
eye and ensure the refractive power of the cornea. Investigators have long been studying the 
mechanism by which epithelial turnover occurs. Based on a collection of studies comparing 
differentiation markers, proliferation capacity, and wound healing capability, it is now widely 
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accepted that there exists a population of stem cells in the epithelium of the corneal limbus, the 
border between the cornea and sclera. 
1.2.1.1 Characterization. In the search for a corneal epithelial stem cell population responsible 
for the regeneration of desquamating corneal epithelium, investigators have characterized 
differences in cell cycle dynamics and protein expression between mature corneal epithelium and 
that of the corneal limbus. DNA labeling using tritiated thymidine of basal cells in the limbal 
region revealed a population of  “slow cycling” cells, a characteristic of stem cells.   Basal 
epithelial cells in the limbus were revealed show differences in protein expression when 
compared to basal cells of the central epithelium 41.   Keratin expression is notably different in 
the limbal basal cells, with a lack of cytokeratins (CK) 3 (a marker of differentiated corneal 
epithelial cells) and 12 but positive staining for CK14 and CK5, two markers associated with 
epithelial stem cells in the skin 42-48. Additionally, basal limbal cells grow clonally as holoclones 
and show greater proliferative capacity, whereas clones from epithelial cells isolated from the 
central cornea are rare and do not proliferate extensively 49,50.  Taken together, the finding of a 
label-retaining cell population with an inverse expression of known differentiation/stem makers 
as well as a difference in proliferation capacity when compared to known mature epithelium, 
these studies strongly support the existence of a stem cell population in the basal layer of the 
corneal limbal epithelium.  
The adult stem cell marker ATP-Binding Casette Sub-Family G Member 2 (ABCG2) has 
proven remarkably useful in the identification and isolation of stem cells, namely mesenchymal 
stem cells derived from bone marrow, due to its ability to efflux Hoechst 33342, a fluorescent 
dye that binds DNA.  Expression of ABCG2 alters cellular fluorescence in the presence of 
Hoechst, allowing sorting of a cell population called the ‘side population’ via FACS, separating 
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the ABCG2+ cells (stem cells) from a heterogeneous population. Side population sorting of the 
limbal epithelium has indeed isolated a population of ABCG2+ stem cells that have greater 
colony-forming efficiency and reduced CK3/CK12 expression compared to central corneal 
epithelium 51,52.  ABCB5, another member of the ATP binding cassette family of proteins, has 
also been identified as a definitive limbal epithelial stem cell (LESC) marker. Experiments in 
both mouse and human revealed that the ABCB5+ limbal epithelium is necessary for proper 
wound healing, corneal development, and epithelial homeostasis 53. Additional stem cells genes 
are expressed by LESC, notable among them are C/EBP-delta and Notch1, proteins known to 
regulate stem cell self-renewal and differentiation 54,55.  
1.2.1.2 Wound healing. In self-renewing epithelia, stem cells are essential for normal tissue 
maintenance because they can regenerate tissue that has been damaged or lost 56-58. Additional in 
vivo studies support the importance of LESC after epithelial debridement, concluding that limbal 
epithelial cells are necessary for the rapid healing of the epithelium 59,60.    Importantly, it has 
been shown that when the basal limbal epithelium is completely removed before corneal 
wounding, vascularization and conjunctivalization result 61. When the limbal cells were in place, 
however, wounds healed without vascularization and cells from the limbal region migrated into 
the central cornea to reform the epithelium 61. In addition to replenishing the mitotic basal cells 
of the central epithelium, cells in the limbal epithelium appear to provide a biological barrier 
preventing conjunctivalization and vascularization of the corneal epithelium after wounding 62,63. 
Expansion of limbal cells in vitro and their subsequent transplantation to central cornea 
can restore epithelial function for more than 10 years in human eyes 64.  In these corneas there is 
no direct evidence that stem cells have repopulated a limbal niche, leaving open the question as 
to whether this tissue, like skin, can be supported by a distributed population of stem cells.  The 
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idea is supported by a study of destrin knockout mice, which show limited or no migration of 
epithelial cells 65. Indeed, human eyes with limbal damage contain patches of normal epithelium 
in the central cornea, suggesting maintenance by local stem cells 66. In a 2008 study, limbal 
tissue expressing beta-galactosidase (ßGal) was transplanted into normal mouse eyes but showed 
no centripetal migration of the labeled cells unless the central epithelium was wounded 67.  Both 
this and a more recent study found that cells from the central epithelium are capable of growing 
as holoclones 67,68.   These studies suggest that rare stem cells may occur in the central 
epithelium and that, where they do occur, they can maintain a stable column of epithelium in a 
manner similar to that of epidermis.  A more recent study reconfirmed limbal stem cell driven 
migration using lineage-tracing expression of fluorescent proteins driven by the promoter for the 
stem cell specific protein cytokeratin 14.  This gene is limited to stem and progenitor cells in the 
limbus, thus all fluorescent cells after induction will represent descendants of those progenitors.  
After induction, fluorescent cells were observed in radial streaks of cells moving toward the 
central cornea at about 11 µm/day in normal, unwounded eyes 69.  These experiments confirm 
the centripetal migration of cells observed in many earlier studies and support the idea that these 
descend from limbal stem cells.  The current state of our understanding leaves open the question 
as to whether stem cells in the central cornea can and do contribute to epithelial homeostasis on a 
long-term basis and whether the centripetal movement of progenitor-derived cells is a 
requirement for maintenance of healthy and stable corneal epithelium.  
In spite of these unresolved questions there remains no doubt in the clinical importance of 
LESC. This is manifest in the condition known as Limbal Stem Cell Deficiency (LSCD).   In this 
relatively rare condition, loss of limbal cells, typically as a result of genetic disease or chemical 
burns, results in conjunctivalization of the cornea, inflammation, neovascularization, pain, and 
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corneal opacity 70.  Standard penetrating keratoplasty involves only central cornea and allogenic 
tissue grafts that do not include limbal tissue experience an increased rate of failure 71-73.  In 
unilateral LSCD, limbal tissue can be harvested from the healthy eye without significant damage 
and cells transplanted on the affected cornea either directly or after expansion in culture74-76.  Use 
of autologous LESC provides long-term stable epithelium to 50-70% of recipient eyes and 
regrafting can improve that result 77,78.  LESC allografts from cadaver eyes often fail 79; however, 
use of biopsy tissue from living relatives and systemic anti-rejection drug therapy has led to 
survival rates for allogenic grafts similar to that of autologous tissue 80.  LESC treatment has 
been carried out on >1000 individuals, becoming the most common and successful of non-
hematopoetic stem cell transplantation procedures, restoring vision to individuals with no 
alternative.  
1.2.2 Corneal Stromal Stem Cells 
Loss of visual acuity due to stromal opacity affects more than 23 million individuals worldwide 
and 4.6 million are estimated to suffer bilateral corneal blindness 3. Although comprehensive 
data are limited, stromal opacity is the source of most corneal blindness, greatly exceeding the 
numbers of individuals affected by LSCD 81-83.   Although fully prosthetic corneal replacements 
are in limited use and acellular prosthetic tissue replacements are in clinical trials, replacement of 
scarred stromal tissue with cadaveric human stromal tissue via corneal transplant (penetrating 
keratoplasty) is the current clinical method of choice 84,85. While transplant is widely successful 
and frequently performed, immune-rejection and available donor tissue are significant limitations 
to the procedure. Indeed, graft survival is only 60% 10 years after surgery, and is progressively 
worse with repeated transplant procedures 86.  
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1.2.2.1 Characterization. Over the past 15-20 years a large number of reports have identified 
and characterized stem cells from various mesenchymal tissues, namely bone marrow 
mesenchyme, adipose tissue, and dental pulp. These stem cell populations are identified by self-
renewal ability, differentiation into multiple cell types, and their ability to grow clonally.  In an 
initial study, a small population of cells exhibiting clonal growth from bovine corneal stroma 
was found to express genes associated with mesenchymal stem cells 87.  Successful stem cell 
isolation from the bovine cornea led to investigation of human corneal tissue for a similar 
population. To achieve this, the well-documented adult stem cell marker ABCG2 was used 88. 
ABCG2 is an ABC cassette membrane transporter which has the ability to efflux the DNA 
binding dye Hoechst 33342, allowing the ABCG2(+) cells to be sorted via fluorescence activated 
cell sorting (FACS).   ABCG2+ cells from the limbal region of human cornea were found to 
represent less than 1% of the total cell population.  These side population (SP) cells were shown 
to grow clonally and exhibited a multipotent differentiation potential, unlike ABCG2(-) cells 
isolated from the same region 89. When cultured in serum-free medium supplemented with 
ascorbic acid and insulin, the human corneal SP cells up-regulated keratocyte specific markers, 
including the corneal stroma specific proteoglycan keratocan 89.   Since the original report, cells 
isolated from corneal stroma with characteristics of mesenchymal stem cells have been described 
in a number of publications 90-97.   Similar properties and the location of these reported stem cells 
support the idea that each study is describing a the same population of mesenchymal stem cells 
largely localized to the anterior limbal stroma 98.  
1.2.2.2 Niche function of stromal stem cells. Several studies have shown limbal mesenchymal 
cells with stem cell properties to be closely associated in vivo with limbal epithelial cells 94,96,98-
103.  The two cell types are also co-isolated in collagenase digests of the limbal tissue 96,99.  In 
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vivo and ex vivo, the two associated cell types exhibit different protein phenotypes, and both 
express stem cell genes 96,99.  A recent three- dimensional electron microscopic analysis of the 
limbal region found the epithelial basement membrane to be fenestrated, providing direct cell-
cell contact between basal epithelial cells and elongated stromal cells in the limbus 103. 
Melanocytes were also associated with the niche complex.  Both LESC and the limbal 
mesenchymal stem cell express N-cadherin, suggesting this cell-cell junction protein provides 
interaction between these cell populations 94,100,104,105.  In vitro, co-culture of LESC with co-
isolated stromal stem cells improved LESC expansion and clonogenicity 94.  Similarly, culture of 
limbal epithelial cells shows improved expansion if it is carried out in the presence of limbal 
mesenchymal cells but less so in the presence of mesenchymal cells from the central stroma99.  
These findings lend credence to the idea that some or all of the mesenchymal stem cells in the 
stroma exist in vivo as a part of a multicellular limbal niche complex, and their presence supports 
the stem cell character of the LESC population.   
1.2.2.3 Anti-inflammatory Properties. In addition to their ability to generate corneal tissues in 
vitro, Human Corneal Stromal Stem Cells (hCSSC) like many mesenchymal stem cells, exhibit a 
potential to mediate immune response.   In the lumican knockout mouse model of corneal haze, 
hCSSC were shown to restore transparency after being injected directly into the stroma 106.   
Even more striking, hCSSC were shown to completely prevent stromal scarring in a mouse 
wound model 107.  Prevention of scarring appears to be the result of paracrine signaling, as tissue 
regeneration occurs both in the anterior stroma where the cells were present as well as the 
posterior where no cells were seen 107. Importantly, in neither in vivo study was T-cell mediated 
tissue rejection observed. This points to both the immune-privilege and immunomodulatory 
characteristics of hCSSC. 
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1.2.3 Corneal Endothelial Progenitor/Stem Cells 
The corneal endothelium of many mammals is notable for its lack of mitotic activity in adults 
and inability to regenerate after damage 108. Upon corneal endothelial cell loss during aging, 
surrounding cells spread out and change shape. If enough cells are lost, the pump function is 
compromised and the cornea becomes edematous and cloudy. Perhaps the most common 
disorder of this nature is Fuch’s Dystrophy, leading to the thickening of Descemet’s membrane 
and corneal edema causing corneal haze. Currently the only treatment option to restore vision 
requires transplantation of donor tissue. While this is largely successful, it does not avoid the 
problems often encountered with transplant operations, namely immune rejection and the 
declining availability of donor tissue.  
1.2.3.1 Characterization. Many laboratories are searching for corneal endothelial stem cells for 
their potential in regenerative medicine. It has been shown that cells with clonogenic potential 
exist in the normal adult corneal endothelium by sphere-formation 109. While these cells did not 
express markers that would be indicative of a stem cell population, clonogenic sphere formation 
and their ability to form a hexagonal monolayer of cells with pump function may indicate that 
they are corneal endothelial progenitor cells 91. As is seen in other ocular tissues, notably the 
corneal epithelium, stroma, and retina, proposed stem cell niches are often found at the periphery 
of the tissue 49,89,110,111. Further characterization of the sphere forming corneal endothelial cells 
revealed that the cells at the periphery of the endothelium have a greater propensity to form 
spheres than do those in the center, as has previously been described in rabbits 112,113. 
Recently a progenitor cell population in human corneal endothelium was identified using 
the established stem cell marker Leucine-Rich Repeat-Containing G-protein Coupled Receptor 5  
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(LGR5) 114. LGR5+ endothelial cells were shown to have greater proliferation capacity than 
LGR5- cells and were located at the periphery of the cornea, both expected characteristics of a 
stem/progenitor cell population. Another laboratory identified a progenitor cell population based 
on expression of the neural crest cell markers p75, SOX9, and FOXC2 115. It was further shown 
that the progenitor cells had high proliferative capacity and demonstrated pump function. While 
there was no statistical difference between the number of p75+ cells between the periphery and 
central corneal endothelium, the cells in the center were dispersed and those at the periphery 
much more concentrated, suggesting the presence of a niche. 
1.2.4 Conclusion 
Corneal wounding and disease often have the devastating consequence of visual impairment or 
blindness. While there are treatment options available when this occurs, tissue rejection and graft 
availability limit the ability to treat the numerous patients in need. Stem cells isolated from the 
cornea may offer an alternative to the current treatment options in that they can be used in an 
autologous fashion. This is already being used for trauma and corneal epithelial disorders such as 
Limbal Stem Cell Deficiency (LSCD) and is widely successful 78,116. Corneal stromal stem cells 
have successfully been isolated from human tissue and animal studies show encouraging results 
that these cells may soon be used to treat stromal scarring. The corneal endothelium appears to 
have a progenitor population that may provide a source of cells for regeneration, though more 
studies need to be completed to demonstrate this. Taken together, the progress made thus far in 
the isolation and use of corneal stem cells for use in the clinic is promising. Though much work 
still needs to be done, an alternative, cell-based treatment for corneal pathologies is achievable. 
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2.0  HUMAN EMBRYONIC STEM CELLS AS AN ALLOGENEIC SOURCE OF 
CORNEAL KERATOCYTES 
2.1 INTRODUCTION 
The cornea is an optically clear, multi-laminar tissue that functions to transmit and focus light on 
the retina. Connective tissue of the corneal stroma constitutes 95% of the cornea’s thickness and 
strength 117. The transparency of the cornea to light depends on the unique molecular 
composition and organization of the extracellular matrix of the stroma, a product of keratocytes, 
specialized neural crest (NC) -derived mesenchymal cells. The stroma is composed of collagen 
fibrils stretching from limbus to limbus in parallel lamellar sheets, forming an organized, 
regularly spaced lattice arrangement that transmits visible light to the interior of the eye. Loss of 
collagen fibril organization, as occurs after trauma or infection, results in scarring and decreased 
transparency, sometimes leading to permanent blindness. 
Currently, the only treatment for many corneal opacities is transplantation of corneal 
allografts. Though this therapy is highly successful, corneal transplants are limited due to a 
worldwide shortage and decreasing availability of donor corneal tissue. A potential approach to 
address these issues is development of material suitable for stromal replacement. Currently, 
several models of tissue-engineered collagen-based corneal substitutes are being developed in 
which scaffolds are made for human keratocytes to populate 118-120. Keratocytes, however, lose 
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the ability to secrete and organize stromal connective tissue after expansion in vitro 121. 
Therefore, there is a need for a renewable source of keratocytes, able to integrate into the 
scaffold and produce stromal connective tissue. Stem cells offer such a potential source for 
construction of biosynthetic corneal tissue 98. Stem cells from adult tissues exhibit a limited 
repertoire of differentiation and typically a limited replicative lifespan in vitro, whereas stem 
cells derived from early embryos appear to have an unlimited lifespan and potential for 
differentiation to any somatic cell type. Pluripotent stem cells, therefore, offer a consistent and 
abundant cell source for development of bioengineering models. 
Human embryonic stem (hES) cells readily differentiate into cells of neural lineage when 
co-cultured with the mouse fibroblast line PA6 122. Recently it has been shown that, during the 
three-week course of neural differentiation, hES cells transiently express a NC phenotype 123-
125.In the first week of co-culture the hES cells express low-affinity nerve growth factor receptor, 
NGFR (also known as CD271 and p75NTR) 125. Expression of this protein is observed on 
migrating neural crest populations during development and is also detected on adult stem cells 
with NC properties 126-128. Separation of NGFR-expressing cells before full neural differentiation 
isolated a population of cells with genetic, phenotypic and functional characteristics of 
embryonic NC cells 125. 
Corneal stroma and endothelium are both tissues of NC lineage. We therefore 
hypothesized that differentiation of hES cells to stromal keratocytes could be effected using hES 
cells that have adopted a NC phenotype. In the current study we captured hES in the NC phase of 
their neural differentiation and induced keratocyte phenotype in pellet culture after a week-long 
expansion in monolayer culture. We found this sequence of culture environments to markedly 
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upregulate expression of mRNAs characteristic of differentiated keratocytes. Furthermore the 
pellet-cultured cells secreted corneal-specific keratan sulfate proteoglycan. 
2.2 MATERIALS AND METHODS 
hES Cell and PA6 Co-Culture 
The murine stromal PA6 cell line (Riken Bioresource Center Cell Bank, Japan) was cultured on 
0.1% gelatin-coated plates in 90% MEM-alpha (Life Technologies, Carlsbad, CA) containing 
10% fetal bovine serum (FBS). The hES cell line WA01 (H1) was obtained from the University 
of Pittsburgh Stem Cell Core under license from WiCell (Madison, WI), and its use was 
approved by the University of Pittsburgh Human Stem Cell Research Oversight Committee. The 
hES cells were grown on Matrigel (BD Biosciences, Franklin Lakes, NJ) in mTeSR-1 basal 
medium (Stemcell Technologies, Canada) and maintained as described in previous protocols 129. 
Differentiation of the hES cells into NC cells during PA6 co-culture was carried out as 
previously described122 with minor modifications. Overgrown and differentiated hES colonies 
were identified and individually scraped off and removed from culture plates with a glass pipette. 
Remaining undifferentiated hES colonies were manually collected and sectioned using a 
StemPro EZPassage tool (Life Technologies). Remaining segmented colonies were mechanically 
dislodged and collected in 50 mL conical tubes, then washed and resuspended in Induction 
Medium (90% BHK21-medium/Glasgow modified Eagle’s medium, 2 mM glutamine, 10% 
knockout serum replacement, 1 mM pyruvate, 0.1 mM nonessential amino acid solution, 0.1 mM 
β-mercaptoethanol, 100 IU/mL penicillin, 100 µg/mL streptomycin) (all from Life Technologies) 
125. The hES colonies suspended in medium were added in a drop-wise fashion to 95% confluent 
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PA6-cultures. The density of plating was approximately 9,000 colonies per 10 cm plate. The co-
cultured plate was incubated at 37°C for 6 days without media changes. 
Immunostaining 
Immunostaining was carried out on 8 µm cryostat sections of donor human corneas fixed in 
3.2% paraformaldehyde overnight. Nonspecific binding was blocked with 10% heat-inactivated 
goat serum in phosphate buffered saline (PBS). Sections were incubated 2 hr at room 
temperature with 1 µg/ml primary antibodies against NGFR (Clone ME20.4, Biolegend, San 
Diego, CA) in 1% bovine serum albumin. After three PBS washes, anti-mouse Alexa-546 
secondary antibodies and nuclear dye DAPI were added and incubated for 2 hr at ambient 
temperature. Samples were imaged using a confocal microscope (Olympus) with a 20× oil 
objective. 
Cell Isolation 
Human keratocytes were isolated from central stroma of fresh human donor corneas (<48 hr 
from TOD) as previously described 89. Briefly, the central cornea was excised, rinsed and 
incubated in 2.4 U/ml Dispase II (Roche Diagnostics, Pleasanton, CA) overnight at 4°C. 
Epithelial and endothelial cells were removed by dissection and debridement, and the stroma was 
minced into 2-mm cubes. Stroma was digested up to 3 hours at 37°C in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 1 mg/ml collagenase type L (Sigma-Aldrich) and 0.2 
mg/ml testicular hyaluronidase (Sigma-Aldrich). Cells were harvested by centrifugation and 
immediately lysed for RNA as described below. 
Quantitative Reverse Transcription-polymerase Chain Reaction (qPCR) 
hES cell samples were collected at days 2, 4, 6, and 8 of PA6 co-culture and lysed in 0.35 ml 
RLT buffer for RNA isolation using the RNeasy mini kit (Qiagen, Valencia, CA). The RNA was 
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treated with DNase I and concentrated by ethanol precipitation. First strand cDNA was prepared 
from 400 ng RNA by reverse transcription using Super Script First Strand Synthesis System for 
RT-PCR (Life Technologies) as described 87. Quantitative RT-PCR (qPCR) was performed using 
SYBR Green reagents (Fisher Scientific Inc.) with the primers listed (Table 1) or with previously 
reported primers for adult human corneal stem cells and keratocytes 89,130. Sequences of primers 
for the human NC genes were compared to their mouse homologues in the NCBI mouse RefSeq 
mRNA library with BLAST (http://blast.ncbi.nlm.nih.gov/) to rule out amplification of mouse 
cDNA by these primers. qPCR with these primers on cDNA from PA6 cells confirmed their non-
reactivity with murine RNA. Amplification was 40 cycles of 15 sec at 95°C and 1 min at 60°C 
after initial incubation at 95°C for 10 min. Total reaction volume was 20 µL, including Maxima 
SYBR Green qPCR Master Mix (containing Maxima Hot Start Tac DNA polymerase, ROX, 
MgCl2, and nucleotides, Fermentas, Fisher Scientific) with cDNA transcribed from 20 ng of 
RNA and 0.2 µM forward and reverse primers. The StepOne Real-Time PCR System (Applied 
Biosystems) was used to generate a dissociation curve for each reaction. Mean threshold cycle 
number (Ct) of triplicate reactions was determined by StepOne Software v2.2.2 and compared to 
the mean Ct value for 18S for the same cDNA and expressed as a power of 2 to calculate relative 
cDNA abundance.  
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Isolation of NGFR+ Cell 
On day 7 of PA6 co-culture, the hES colonies were dislodged with Accutase (Life Technologies) 
and triturated by pipetting into a single-cell suspension. After rinsing twice, the cells were 
filtered through a 70 µm cell strainer to remove any clumps and counted. The cells were washed 
twice in PBS containing 0.5% bovine serum albumin and ethylene-diamine-tetraacetic acid, 0.1 
mM, then resuspended in 0.1 mL of the same buffer. After adding Fc blocking reagent (Miltenyi 
Biotec, Auburn, CA), the cells were fluorescently labeled by incubating with APC-labeled anti-
NGFR antibody, washed, and incubated with magnetic beads covalently linked to anti-APC 
antibodies (Miltenyi Biotec). The MACS Cell Separation system (Miltenyi Biotec) was then 
used to separate NGFR+ magnetically labeled cells according to the manufacturer’s instructions. 
Flow-through and Bound cell populations were collected from the MACS columns and 
analyzed as to NGFR by flow cytometry and for NC gene expression by qPCR. For flow 
cytometry, 105 cells in 0.1 ml PBS were incubated with 2 µg APC-labeled antibody to NGFR 
(Miltenyi Biotec) or with APC-labeled nonspecific isotype control antibody along with Fixable 
Violet Live/Dead stain (Life Technologies) for 30 min on ice. Cells were rinsed by 
centrifugation and then fixed in 2% paraformaldehyde in PBS. Staining was determined by flow 
cytometry on a BD Biosciences FACS Aria III flow cytometer. 
 
 
 
 
 
Table 1 Primer sequences used for qPCR  
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Cell Expansion and Pellet Culture 
NGFR+(Bound) cells were cultured as monolayers in 10 cm tissue culture dishes coated with 
FNC (AthenaES, Baltimore, MD) in MEM-alpha with 10% FBS or alternately on plates coated 
with poly-L-ornithine/laminin/fibronectin 123 in N2 Medium [DME/F12 medium (Sigma) with 
N2 supplement (Life Technologies), 10 ng/ml FGF2 (Sigma) and 10 ng/ml EGF (Sigma)]. 
Because of the presence of abundant PA6 cells, flow-through cells were not further cultured. 
After 7 days, the cultured Bound cells were collected for qPCR analysis and also transferred to 
pellet culture to induce keratocyte-differentiation 130. Briefly, 1.8×105 cells were collected in 15-
mL conical tubes and centrifuged at 1500 rpm for 5 minutes to form pellets. The pellets were 
cultured 2% FBS in DME-F12 medium and after 2 days transferred to keratocyte differentiation 
medium (KDM): Advanced DMEM with 10 ng/mL FGF2, and 0.1 mM ascorbic acid-2-
phosphate 130. Although cells in pellets maintained viability based on staining with Calcein AM, 
the pellets were difficult to disperse and were not passaged. 
For protein expression analysis, NGFR+ cells were cultured for two weeks as pellets in 
DMEM/F-12, with 1 mM ascorbate-2-phosphate, ITS (Gibco), 0.1 mM non-essential amino 
acids, 10 ng/mL FGF2, and antibiotics as above. Proteoglycans were isolated from conditioned 
media by ion exchange chromatography as described previously 31, dialyzed, dried, and biotin 
labeled using sulfosuccinimidyl-6-(biotinamido) hexanoate (Sulfo-NHS-LC-Biotin, Fisher 
Scientific) at 2 mg/ml in 0.1 M NaHCO3, 1 hr at room temperature. Cornea-specific keratan 
sulfate proteoglycans were immune precipitated with a polyclonal antibody to keratocan  31,121 or 
a monoclonal antibody to keratan sulfate, J19 131, bound to protein G-magnetic beads 
(Dynabeads, Life Technologies). Keratan sulfate on half of each sample was digested with endo-
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beta-galactosidase121 (QA-Bio, Palm Desert, CA) 0.05 U/ml, 2 hr at 37°C. Digested and 
undigested samples were separated by electrophoresis on 4%–20% SDS-PAGE gel and 
transferred to a PVDF membrane. Membranes were probed with streptavidin-IR700 dye and 
imaged on a LiCor Odyssey Imaging System 132. 
2.3 RESULTS 
2.3.1 Selecting Keratocyte Precursor Cells by NGFR Expression 
We and others have shown that the limbal (peripheral) region of the corneal stroma contains 
mesenchymal cells with stem cell properties 98. These cells have the ability to differentiate to 
keratocytes in vitro and in vivo 106,130,133. Consistent with the neural crest origin of the stroma, 
limbal stromal cells express several proteins characteristic of neural precursor and neural crest 
cells including nestin and Six2 130. The cell surface low affinity nerve growth receptor (NGFR) is 
expressed on migrating embryonic neural crest cells as well as a number of adult stem cells, 
particularly those with neural crest character 126,128,134. NGFR has also been detected in limbal 
epithelial and stromal cells of human cornea 135,136. Immunohistochemistry confirmed the 
observation that cells in the limbal stroma express NGFR (Figure 6A) and found that few or no 
cells in the central stroma stained for NGFR (Figure 6B). Because hES cells exhibit transient 
expression of NGFR when induced to differentiate to the neural lineage 125, we adopted the 
rationale that isolation of hES cells expressing NGFR might provide a source of cells with the 
potential to differentiate to keratocytes. 
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2.3.2 Isolation and Characterization of hES-derived NC Cells 
When hES cells are co-cultured with mouse embryonic fibroblast PA6 cells (Figure 7A) 
they differentiate to neural cells. Early in this process the hES cells transiently express a NC 
phenotype 125. We found that expression of several characteristic NC genes (NGFR, SNAI1, 
NTRK3, SOX9, and MSX1) was upregulated after two days of the co-culture (Figure 8). 
Consistent with previous reports, expression of these NC genes plateaued at days 6–8, after 
which the cells transitioned into neural cell phenotypes 89,118,120.  
 
 
 
 
Figure 6 Limbal Stromal Cells Express NGFR Protein 
Cryosections of cornea from a 34 yr old donor were immunostained with antibody to NGFR 
(p75ntr) protein (red) and counterstained with DAPI (blue). (A) Shows anterior stroma and 
epithelium at the limbus. (B) Shows central cornea. Bars in the images indicate 50 µm. 
Chan, Hertsenberg et. al. doi:10.1371/journal.pone.0056831.g001 
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From 6-day induced hES cells, a population of cells expressing the cell surface NC 
protein NGFR was selected using magnetic beads attached to anti-NGFR antibody (Bound 
Cells). Cells expressing lower levels of NGFR (Flow Through) were also collected. Flow 
cytometry of these populations (Figure 9) showed that the affinity procedure enriched for cells 
with the NGFR cell surface marker, increasing its abundance 4-fold in the Bound-cell population 
compared to starting material. 4.9×106 cells were recovered from a starting population of 
7.8×107 total (hES+PA6) cells representing about 6% of the total cells. Viability of the Bound 
cells was >95%. 
Figure 7 Culture and Differentiation of hES Cells 
A) Shows colonies of hES cells cultured on monolayers of PA6
mouse cells to induce neural differentiation. (B) NGFR+ derived 
hES cells after 6 days of co-culture were cultured as monolayers 
in serum-free N2 medium. The cells remain small and exhibit 
polygonal morphology. (C) NGFR+ derived hES cells are 
cultured as a monolayer in serum-containing alpha-MEM 
medium. The cells form aligned, spindle-shaped confluent 
monolayers. (D) Pellet from alpha-MEM cultured cells after 2-
week culture. Cells are small, tightly packed and difficult to 
disperse. Bars show 200 µm. Chan, Hertsenberg et. al. 
doi:10.1371/journal.pone.0056831.g002 
Figure 8 Co-Culture with PA6 Cells Induces Neural Crest 
Gene Expression in hES Cells 
hES cells were co-cultured with PA6 cells. RNA was isolated at 
post-induction days (PID) 2, 4, 6, and 8. Expression of 
characteristic neural crest (NC) marker genes was determined by 
qPCR using human-specific primers. Expression levels are 
calculated relative to untreated hES cells (hES = 1). Error bars 
show the standard deviation (S.D.) of triplicate analyses. Chan, 
Hertsenberg et. al. doi:10.1371/journal.pone.0056831.g003 
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Because the cells introduced to the MACS columns represented a mixture of hES and 
murine PA6 feeder layer cells, it was important to verify that PA6 cells were not collected in the 
NGFR+ fraction. Presence of mRNA for a constitutively expressed mouse gene TBP1137 was 
compared using qPCR from the starting cells and the cells after isolation. The expression relative 
to the pure PA6 line is shown (Table 2). By this measure, the recovered NGFR+ cells were found 
to be >99.99% human, similar to the pure hES cell cultures. This proportion remained after 
expansion and passage of these cells. Therefore, magnetic-activated cell sorting is an effective 
way of isolating a NGFR+ population of cells from PA6 co-cultured treated hES cell culture 
without contamination from the murine feeder layer. 
Table 2 Mouse mRNA expression in isolated cell populations. 
Chan, Hertsenberg, et. al. 
doi:10.1371/journal.pone.0056831.t002 
 
Figure 9 Magnectic Activated Cell Sorting (MACS) Selects for a Population of NGFR+ Cells 
Single cell suspensions of hES cells after 6 days of co-culture with PA6 cells were stained with 
APC-labeled NGFR antibody and analyzed by flow cytometry either before or after separation of 
NGFR-positive cells by MACS columns as describe in Methods. The blue trace shows the cells 
stained with non-specific isotype-matched control antibody. (A) Unfractionated hES+PA6 co-
culture. (B) Flow-through, cells not bound to the NGFR MACS column. (C) NGFR+ cells bound 
and released from MACS column. The vertical bar marks the population containing <0.1% non-
specific control cells (blue trace). The calculated percentages of the population (red trace) with 
positive staining are listed on the graph. 
Chan, Hertsenberg, et. al. doi:10.1371/journal.pone.0056831.g004 
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Quantification of NC gene expression in the isolated (Bound) cell population (Figure 10) 
found NGFR expression to be enriched 6-fold compared to Flow-though cells. Expression of 
other NC marker genes (NTRK3, SNAI1, and SLUG) was significantly enriched in the NGFR+ 
cells, but two NC markers (SOX9 and MSX1) did not appear to be specifically associated with 
the NGFR+ cell population. 
 
2.3.3 Keratocyte Differentiation of hES-derived NGFR+ Cell Population 
Adult stem cells isolated from the human corneal stroma exhibit a phenotype different from 
differentiated keratocytes, but with similarities to mesenchymal stem cells from bone marrow 
87,89,130. These cells can be distinguished from keratocytes by expression of several stem cell-
associated genes, and will differentiate into keratocytes when cultured as substratum-free 
Figure 10 Expression of Neural Crest Genes after PA6 Co-Culture in MACS Sorted NGFR+ Cells 
Expression of human NGFR, NTRK3, SOX9, SNAI1, SLUG and MSX1 was determined in 6-day PA6-cocultured 
hES cells after separation of NGFR+ (Bound) and NGFR- (Flow through) by MACS columns as described under 
Methods. Expression levels were calculated by qPCR relative to hES cells (hES expression = 1). Error bars show 
S.D. of triplicate analyses. Asterisks show significantly (p<0.05) increased expression in bound cells as 
determined by Student’s t-test.  
Chan, Hertsenberg, et. al. doi:10.1371/journal.pone.0056831.g005 
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floating pellets in serum-free medium containing ascorbic acid-2-phosphate and FGF2 130. Our 
initial attempts to maintain the isolated NGFR+ cells directly in pellet cultures led to cell death, 
but we found that expansion of these cells in monolayer culture (as shown in Figure 7B and C) 
maintained their viability. We compared isolated NGFR+ cells and the subsequent monolayer 
cultures for expression of six genes (Figure 11) previously identified as abundant in human 
corneal stromal stem cells, (Pax6, Nestin, Kit, Notch1, Six2, BMI1) 130. All six genes were 
expressed in the NGFR+ cells and in culture, expression was maintained for all but PAX6 which 
was decreased by >90% in the cultured cells. Expansion in serum-free conditions in the presence 
of EGF, FGF2 and N2 supplement (N2 medium, Figure 7B) was marginally better at maintaining 
stem cell gene expression than culture in 10% fetal bovine serum in MEM-alpha medium 
(MEM-FBS, Fig. 5C). Passage in MEM-FBS reduced the adult stem cell expression even further 
(not shown). 
Figure 11 Expression of Adult Stem Cell Markers After Monolayer Culture 
Expression of genes distinguishing adult corneal stem cells from keratocytes: PAX6, NES, NOTCH1, 
SIX2, BMI1, and KIT, was examined in the NGFR+ cells and in these cells after culture of the cells one 
week as monolayers in MEM-FBS or in N2 media as described in Methods. Gene expression was 
determined by qPCR relative to NGFR+ cells (set = 1). Error bars show S.D. of triplicate analyses. 
Chan, Hertsenberg, et. al. doi:10.1371/journal.pone.0056831.g006 
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Cells from the N2 and MEM-FBS monolayer cultures were transferred to differentiation 
medium as pellets (Figure 7D) for two weeks and assayed for expression of six genes that are 
highly expressed in keratocytes (Figure 12). We saw that aquaporin-1 (AQP1) was increased 24-
fold, PTGDS 20-fold, B3GNT7 10-fold, and ALDH3A1 100-fold when compared with the 
NGFR+ cells. Most notably, expression of keratocan (KERA), a cornea-specific proteoglycan 
present in stromal extracellular matrix, was increased over 10,000-fold. 
The most characteristic molecular identifiers of keratocytes are the keratan sulfate 
proteoglycans 138. These are a group of three proteins, one of which being keratocan, modified by 
highly sulfated keratan sulfate glycosaminoglycan chains. Biosynthesis of corneal keratan sulfate 
is reported to require two cornea-specific enzymes, beta3-GnT7 (EC 2.4.1), a 
glycosyltransferase, and corneal N-acetylglucosamine 6-sulfotransferase (EC 2.8.2.17) 139. 
Messenger RNA for keratocan (KERA) and for these two enzymes (B3GNT7, CHST6) are all 
Figure 12 Upregulation of Keratocyte Specific Gene Expression after Pellet Culture 
Expression of six genes, previously identified as up-regulated during keratocyte differentiation, was 
determined after 2 weeks in pellet cultures derived from either MEM+FBS or N2 monolayer cultures 
as described in Methods. Gene expression is calculated relative to the NGFR+ derived hES cells. 
Error bars represent S.D. of triplicates. All genes were significantly (p<0.05) upregulated in pellets 
compared to NGFR+ cells except for CHST6. Asterisks show cases in which pellet culture induced a 
significant (p<0.05) increase in gene expression compared to the monolayers cultures. 
Chan, Hertsenberg et. al. doi:10.1371/journal.pone.0056831.g007 
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markedly increased when adult stem cells differentiate to keratocytes 133, so it seemed curious 
that the CHST6 showed little upregulation as hES-derived cells began expressing keratocan. To 
better understand this phenomenon we compared expression of the biosynthetic genes in hES-
derived cells with that of human corneal fibroblasts (HCF), cells that do not synthesize keratan 
sulfate, and with freshly isolated uncultured human keratocytes 89. Additionally, we found that 
the NGFR+ cells as well as the monolayer cultures all express high levels of the keratan sulfate 
sulfotransferase (CHST6) mRNA, almost equivalent to that in uncultured keratocytes and that 
the glycosyltransferase (B3GNT7) mRNA was also highly abundant compared to the level in 
corneal fibroblasts (Figure 13). Cells in MEM-FBS had reduced mRNA abundance for these 
genes, and when cultured as pellets, expressed little more than the HCF. Pellet cultures from 
cells expanded in N2 medium, however, showed levels of expression almost identical to those in 
keratocytes. These results suggest that CHST6 and B3GNT7 may not be upregulated in pellet 
culture because they are already expressed at high levels by the NGFR+ cells. 
Figure 13 Expression Levels of CHST6 and B3GNT7 
Expression of CHST6 and B3GNT7 in the hES-derived cells was compared relative to that of human 
corneal fibroblasts (cells that do not secrete keratan sulfate) and to freshly isolated stromal keratocytes as 
described in Methods. Levels of both genes are comparable in NGFR+ cells to those in keratocytes but are 
reduced in the presence of FBS. Cell cultures are those described in Methods. Error bars show S.D. of 
triplicate analyses. 
Chan, Hertsenberg, et. al. doi:10.1371/journal.pone.0056831.g008 
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Secretion of high molecular weight keratan sulfate proteoglycans (KSPG) is a unique 
phenotypic property of keratocytes and is required for corneal transparency. High expression of 
KERA, B3GNT7 and CHST6 suggests that these specialized proteoglycans may be produced by 
the hES-derived pellet cultures. Antibodies to keratocan precipitated a high molecular weight 
(>100 kDa) heterogeneous protein from pellet-conditioned culture media (Figure 14, lane 3). 
This material was sensitive to digestion by endo-beta-galactosidase (Figure 14, lane 4), a keratan 
sulfate-degrading enzyme. Presence of the keratan sulfate in this fraction was confirmed by 
immune precipitation with anti-keratan sulfate monoclonal antibody J19 and subsequent 
digestion with endo-beta-galactosidase (Figure 14, Lanes 7 and 8). These results demonstrate 
secretion in the pellet cultures of molecular components of corneal stroma that represent unique 
biosynthetic products of differentiated keratocytes. 
Figure 14 Secretion of Corneal Keratan Sulfate Proteoglycans In Pellet Culture 
Proteoglycans were isolated from culture medium before (Lanes 1,2,5,6) or after (3,4,7,8) three-week incubation with 
hES pellets. The proteoglycan fractions were biotin- labeled and immune-precipitated with antibodies against keratocan 
(anti-Kera) (lanes 1–4) or keratan sulfate glycosaminoglycan (anti-KS) (lanes 5–8). Half of each sample was digested 
with endo-ß-galactosidase (as described under Methods) to hydrolyze keratan sulfate, and samples were separated by 
SDS-PAGE, transferred to PVDF membranes and biotinylated proteins detected with avidin-labeled infrared dye as 
described in Methods. Presence of biotinylated proteins migrating as a broad, heterogeneous >100 band typical of 
keratan sulfate proteoglycan (KSPG - bracket on the left) was present in lanes 3 and 7. Sensitivity of this material to 
digestion with keratan sulfate-specific glycosidase (lanes 4 and 8) demonstrates presence of keratocan-linked keratan 
sulfate, a unique keratocyte biosynthetic product. 
Chan, Hertsenberg, et. al. doi:10.1371/journal.pone.0056831.g009 
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2.4 DISCUSSION 
In this study, we show that hES-derived cells expressing NC marker genes can be induced to 
differentiate into cells expressing keratocyte-specific genes and extracellular matrix components. 
Using a well-established co-culture procedure (Figure 7A) that induces neuronal differentiation 
in H1-hES cells, we selected a population of NGFR-expressing cells. As previously reported, 
these cells express several characteristic NC marker genes. The isolated NGFR+ cells were 
expanded in monolayer cultures during which time they continued expression of several genes 
we previously identified in adult corneal stromal stem cells 130. The monolayer cells were then 
incubated as free-floating pellets, a condition we previously found to induce the keratocyte 
phenotype in adult stem cells 130. In the pellets, expression of genes that characterize the 
phenotype of keratocytes was detected, including KERA, AQP1, ALDH3A1, CHST6, B3GNT7 
and PTGDS. To confirm the phenotype we demonstrated the presence of keratan sulfate 
proteoglycans containing both keratocan and high-molecular weight keratan sulfate in 
conditioned media from the pellet cultures. These matrix components are tissue-specific 
biosynthetic products of keratocytes present only in corneal stroma. Previously, keratocan 
production has been induced in various multipotent stem cells including adult adipose-derived 
stem cells 131, corneal stromal stem cells 130, and bone marrow mesenchymal stem cells 140. The 
current results provide convincing evidence that stromal extracellular matrix can also be 
produced by pluripotent stem cells. 
An important aspect of the selection process was the use of NGFR-expressing cells. 
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Selection of NGFR+ cells allowed isolation of a population with neural crest phenotype, free of 
mouse feeder cells. NGFR is a cell surface protein expressed mostly in migrating NC cells in 
embryos 127. Stromal keratocytes are derived from NC, and adult human cornea was recently 
reported to express mRNA for NGFR 141. The data in Figure 6 confirm previous reports 135,136 
that NGFR protein is present on cells in the limbal stromal cells. Furthermore, this figure adds 
new information that little NGFR protein is present in the central corneal stroma. Our 
observation that hES-derived cells expressing NGFR have the potential to become keratocytes is 
consistent with the idea that the NGFR+ cells in limbal stroma may be keratocyte progenitor 
cells. 
Immobilized anti-NGFR antibodies have been previously used to select NC–like 
populations from hES cells during neural differentiation 125. This approach clearly enriched for a 
NGFR+ population, but according to Figure 9 the isolated population contained a substantial 
sub-population of NGFR- cells as well. In the future we may obtain a more potent population by 
multiple rounds of selection or by fluorescence-activated cell sorting (FACS). NC gene 
expression by these cells suggests the differentiating hES cells were heterogeneous because not 
all of the NC gene expression segregated equally with the NGFR+ cells. NGFR mRNA was 
enriched by at least 6-fold in the NGFR+ selected cells but other NC markers much less so. One 
advantage of the selection process was that it completely eliminated mouse PA6 feeder cells 
(Table 2). 
We found the NGFR+ population unable to differentiate to keratocytes directly and 
introduced an intermediate monolayer culture of the NGFR+ cells. During this culture, 
expression of genes previously found to be expressed in stromal stem cells, particularly that of 
PAX6, was reduced. Fetal bovine serum and expansion of the cells beyond a single passage 
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appeared to be detrimental to their ultimate ability to differentiate. Although this culture stage 
appears to be essential, it seems likely that additional optimization of conditions of this stage of 
the process might ultimately provide a more efficient differentiation. 
The ability of adult cells to differentiate to keratocytes appears to require the presence of 
soluble ascorbate and culture in an environment allowing formation of a three-dimensional cell 
construct 130,131,133,142-145. We originally found that in serum-free medium containing ascorbate-2-
phosphate, insulin, and FGF2, primary keratocytes form free-floating spheres that release from 
the plastic surface, adapting a highly differentiated phenotype 143. Spherical aggregates of adult 
stem cells from cornea, adipose, and trabecular meshwork tissues formed by centrifuging the 
cells into a pellet also express keratocyte genes and organize a cornea-like extracellular matrix 
130,131,142. Based on these studies, we believe that expression of an array of keratocyte-specific 
genes by hES-derived NGFR+ cells cultured under these same conditions provides a strong 
argument that these cells have become functional keratocytes. 
This argument was bolstered by the detection (in Figure 14) of corneal keratan sulfate 
proteoglycans secreted by the pellets. These data document secretion of a high molecular weight 
(>100 kDa) heterogeneous protein that precipitates with antibodies to keratocan and keratan 
sulfate and is also degraded by a glycosidase that breaks down keratan sulfate. Since this 
molecular form of proteoglycan is uniquely secreted by keratocytes in vivo, we believe this 
experiment provides incontrovertible evidence that the hES-derived cells have adopted a 
function previously only observed in corneal keratocytes. 
Production of keratocytes from pluripotent cells has significant implications for cell-
based therapy and tissue engineering for treatment of corneal diseases. Based on these results, 
pluripotent hES cells could represent a consistent, inexhaustible source of tissue for the surgical 
 37 
treatment of severe corneal opacities. Furthermore, induced pluripotent stem cells derived from 
adult somatic cells could be used in place of human embryonic stem cells to provide autologous 
material for bioengineered corneal matrix or for direct cell-based therapy having a decreased risk 
of rejection and in greater supply than donor tissue. 
In summary, this study has developed methodology to induce differentiation of hES cells 
into cells with a gene-expression phenotype similar to that of adult human keratocytes. This 
method may prove useful in the ongoing development of cell-based treatment for corneal 
blindness. 
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3.0  LIMBAL BIOPSY-DERIVED CORNEAL STROMAL STEM CELLS FOR 
AUTOLOGOUS TREATMENT OF CORNEAL SCARRING 
3.1 INTRODUCTION 
The cornea is the first tissue through which light enters the eye and serves a critical role in 
focusing it onto the retina. When the cornea is injured or inflamed, normally quiescent cells of 
the corneal stroma, the keratocytes, transform into fibroblasts to repair the damage by secreting 
scar tissue 31,146. The presence of fibrotic extracellular matrix (ECM) components in stromal 
scars results in scatter of incident light, causing a deterioration of visual function 147,148. Visual 
impairment and blindness owing to corneal scarring affects millions worldwide 3,4 and is the 
commonest indication for corneal transplantation (penetrating keratoplasty) in the developing 
world 149. Penetrating keratoplasty is the most widespread organ grafting procedure and usually 
highly effective in improving vision 150; however, global demand for donor corneal tissue vastly 
exceeds its availability. Moreover, post-operative complications, particularly immune rejection, 
reduce the functional survival time for corneal allografts 86, especially in developing countries 
151.  For these reasons there is increasing interest in the development of therapeutic alternatives to 
corneal transplantation, including stem cell therapy, cell-free collagen scaffolds, bioengineered 
constructs, and corneal prostheses 84,98,152,153. 
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The discovery of multipotent stem cells in the corneal stroma 89,130 has opened up the 
possibility of developing a cell-based approach to treating blinding corneal stromal disorders. In 
a mouse model of corneal opacity, human stromal stem cells were effective in regenerating 
normal corneal ECM and repairing collagen fibril defects 106. The ability of mesenchymal stem 
cells to restore corneal transparency in lumican-knockout mice was subsequently confirmed 
using umbilical cord stem cells 154.  The presence of adult stem cells of mesenchymal lineage in 
human corneal stroma has been the subject of several reports 92,98,155,156. Mesenchymal stem cells 
are immune-suppressant and therefore may have a role not only in remodeling but also in 
preventing inflammation, scarring, and immune rejection of transplanted tissue 157,158.  
The transitional region between optically clear cornea and opaque sclera, known as the 
limbus, is the location of a population of epithelial stem cells that can be obtained by biopsy and 
expanded in vitro. Limbal epithelial cells, obtained from surface biopsy, have been used 
successfully for autologous treatment of limbal stem cell deficiency in clinical trials 78,80,159-161. 
Cultures from limbal biopsy procedures also contain a population of mesenchymal cells with 
properties similar to mesenchymal stem cells from bone marrow 92.  Other studies also have 
identified mesenchymal stem cells in the limbal region of the corneal stroma 92,155-157. We have 
proposed that these reports all describe a single population of cells, the corneal stromal stem cells 
we have shown to differentiate to keratocytes and to regenerate stromal tissue in vivo 98. The 
implication that corneal stromal stem cells may be present in biopsy samples suggests their 
availability for autologous use.  
Our current study addresses the hypothesis that mesenchymal cells obtained from limbal 
biopsy tissue from human corneas can be expanded in a culture medium containing autologous 
serum and can differentiate to keratocytes with the potential for use in cell-based therapy. To 
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demonstrate this property we used a therapeutic model in which human limbal biopsy–derived 
stromal cells (LBSCs) embedded in fibrin gel were applied to the surface of a healing murine 
debridement wound.  We report that human stromal cells derived from limbal biopsies can not 
only differentiate to functional keratocytes in vitro, but also induce regeneration of damaged 
stromal tissue in vivo resulting in a matrix indistinguishable from that of native cornea. 
3.2 MATERIALS AND METHODS 
Study Design 
The purpose of this study was to determine if mesenchymal cells present in human corneal 
limbal biopsies (LBSCs) differentiate into corneal keratocytes in vitro, and whether they can 
prevent corneal scarring in a murine model in vivo. In vitro, stem cell potential was assessed 
using clonogenic potential, sphere formation, and expression of stem-cell genes. Keratocyte 
differentiation was examined by gene and protein expression and by secretion of typical stromal 
ECM. In vivo, LBSCs were introduced into mouse corneal debridement wounds and the effect 
on corneal transparency, fibrotic EMC expression, and ECM ultrastructural organization was 
assessed.  Statistical analyses used two-sided t-tests and two-way analysis of variance 
(ANOVA). In vivo experiments were designed to provide a power of 0.8 based on results from 
our previous study (23) using animals randomized as to treatment.  Collection and analysis of in 
vivo data was carried out with observers blinded as to treatment groups. No adverse events were 
observed and no data points were excluded from analyses.  
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Limbal biopsy 
Human corneo-scleral rims from donors younger than 60 yo with less than 5 days of preservation 
were obtained from the Center for Organ Recovery and Education (www.core.org). Rims were 
rinsed twice in Dulbecco’s modified Eagle’s medium (DMEM/F12) containing gentamicin, 
penicillin, and streptomycin for 10 minutes each. As illustrated in Figure 15, under a dissecting 
microscope residual conjunctiva was grasped with a toothed forceps and sub-conjunctival 
dissection was carried out using Vannas scissors towards the anatomical limbus extending 0.5 
mm into the clear cornea. Conjunctiva was excised and dissection of anterior limbal tissue was 
carried out circumferentially in the same plane. An annular ring of tissue consisting of the 
superficial limbal epithelium and stroma with 0.5 mm of cornea and sclera on either side was 
excised. This was divided into equal halves and each half was further divided into 4 equal 
segments (total of 8 segments) ~4.5 mm each.  
Isolation and culture of stromal cells 
Four limbal segments were incubated in 0.5 mg/ml collagenase (Sigma-Aldrich, type L) 
overnight at 37ºC, without epithelial removal. The remaining 4 segments were first incubated for 
40 minutes in Dispase II neutral protease (Zen Bio) at 37ºC. Epithelial cells were removed by 
gentle scraping, and the stripped limbal segments were incubated in collagenase similar to the 
first four segments. The digests were ticturated, incubated an additional hour, and filtered 
through a 70-µm nylon screen to obtain a single-cell suspension. Cells obtained from each 
segment were seeded onto FNC-coated wells of a 12-well tissue culture plate in stem cell growth 
medium 106 containing 2% (v/v) fetal bovine or pooled human serum (Innovative Research).  
Culture media were changed every other day and cells were sub-cultured by brief digestion with 
TrypLE Express (Life Technologies) when 90% confluent into 6-well plates, 25 cm2 T-flasks, 
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and 175 cm2 T-flasks at passage 1, 2, and 3 (P1, P2, P3) respectively. Corneal fibroblasts were 
isolated by collagenase digestion of the peripheral 1-2 mm corneal rim left behind after excising 
the limbus and the sclera and expanded in DMEM/F12  with 10% FBS and used at passage 4-6 
89.   
Clonogenic Assay (CFU-f) 
P3 cells were plated at a density of 250 cells in a 10-cm diameter dish (~5 cells/cm2) in the same 
media that were originally used to culture the cells. After 10 days, media were removed and cells 
were fixed with cold methanol 10 min then stained with 0.1% crystal violet in 20% ethanol for 5 
minutes. Colonies of >50 cells were evaluated as to size and number using Fiji (ImageJ) 
software. Colony counts were determined in duplicate for cell lines derived from 4 donor corneas 
(n=8).  Diameter of colonies in 4 dishes was determined for each condition (n>400). 
Sphere Formation  
P3 LBSCs were placed in 6-well plates coated with poly(2-hydroxyethyl methacrylate)   
(polyHEMA) 162 at a density of 3000 cells/well in sphere medium: Advanced DMEM 
(containing glutaMAX, Gibco 12491), B27 (1:50), 10 ng/mL fibroblast growth factor basic, 20 
ng/mL epidermal growth factor, 50 ug/mL gentamicin, 100 ug/mL streptomycin and 100 IU/mL 
penicillin. The individual spheres were photographed and collected for RNA analysis on day 7.  
Differentiation to keratocytes 
P3 LBSCs were cultured on collagen gel-coated 12-well plates at a density of 100,000 cells per 
well. After 24 hours, medium was changed to keratocyte differentiation medium (KDM) 
consisting of Advanced DMEM (containing glutaMAX, Gibco 12491), ascorbate-2-phosphate (1 
mM), FGF2 (10 ng/ml) and TGF-ß3 (0.1 ng/ml) 153. One week later the gel was digested with 0.5 
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ml of collagenase (2 mg/ml, Sigma-Aldrich, type L). Cells were collected by centrifugation and 
lysed in RLT buffer (Qiagen) for RNA isolation.  
Gene expression before and after differentiation 
RNA isolated by Qiagen miniPrep was transcribed into cDNA using SuperScript III (Life 
Technologies) and analyzed for expression of stem cell (ABCG2 and Nestin) and keratocyte 
(ALDH, AQPR1, CHST6, Keratocan and PTDGS) gene markers using procedures and primers 
previously described 106,130,163. Assessment of mRNA copy numbers was carried out using 
standard curves based on linearized plasmids containing the amplified sequences 163.  
Production of Stromal Matrix 
P3 cells were plated on 15 mm diameter PLC aligned nanofiber inserts (Nanofiber Solutions 
#242402) in a 24-well plate at a density of 20,000 cells per well. After 24 hours in stem cell 
growth medium, cultures were shifted to KDM. The medium was changed every 3 days for one 
month after which the tissue was fixed in paraformaldehyde and immunostained (as below) for 
collagen I, f-actin using phalloidin, and nuclear DNA with 4',6-diamidino-2-phenylindole 
(DAPI) 133,153. Stained constructs were imaged using a Fluoview 1000 Olympus confocal 
microscope with a 20X oil immersion objective. Z-stack images captured optical sections 
throughout the construct and were used to determine construct thickness. Proteoglycans isolated 
from the culture medium were separated by polyacrylamide gel electrophoresis and detected by 
immunoblotting using antibody J19 to detect keratan sulfate, as described previously 153.  
Immunostaining 
Immunostaining of mouse tissue was carried out on 8 µm cryostat sections fixed overnight in 3% 
paraformaldehyde and blocked using 10% heat-inactivated goat or donkey serum in phosphate 
buffered saline (PBS). Primary antibody was incubated at 4ºC overnight. Primary antibodies 
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used were: human keratocan (1:150, Gift from Chia-Yang Liu 164), human-specific collagen I 
(1:100, Sigma C2456), decorin (1:100, Santa-Cruz Biotechnology, SC-22753), biglycan (1:80, 
R&D Systems AF2667), fibronectin (1:80, Abcam, ab26245), or tenascin C (10 µg/mL, R&D 
Systems, MAB 2138). To detect hyaluronan (HA) tissue was fixed in ice-cold 4% 
paraformaldehyde, 70% ethanol, 5% glacial acetic acid (v/v) for 10 minutes. After washing 3 
times in PBS, slides were blocked using an Endogenous Biotin-Blocking Kit (Life Technologies 
E-21390) and stained with biotinylated HABP (1:100, Millipore 385911) overnight at 4ºC. Slides 
were then washed 3 times in PBS and stained with AlexaFluor 546 conjugated Streptavidin (Life 
Technologies S-11225) at 1:1000 for 2 hours at room temperature. Slides were subsequently 
washed 3 times in PBS before staining with secondary antibody and DAPI for 2 hours at room 
temperature. Slides were imaged using the Olympus Fluoview 1000 confocal microscope with 
20X or 40X oil objective. 
Corneal Debridement 
All animal procedures were done in accordance to The Association for Research in Vision and 
Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research 
and approved by the Institutional Animal Care and Use Committee (IACUC) of the University of 
Pittsburgh. Debridement procedures were done as previously described 158. Briefly, 7-week old 
female C57Bl/6 in randomized groups of 6-10 were anesthetized by intraperitoneal injection of 
ketamine (50 mg/kg) and xylazine (5 mg/kg). Our previous study and power analysis determined 
that at least 6 eyes were required for statistical significance in OCT analysis, and that 2-weeks 
and 4-weeks provided appropriate time points for analysis of gene expression and fibrosis 158.  
One drop of Proparacaine Hydrochloride (0.5%) was added to each eye before debridement. 
Corneal epithelial debridement was performed by passing an Algerbrush II (The Alger 
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Company) over the central 2 mm of the mouse cornea. Once the epithelium was removed, a 
second application of the Algerbrush II was used, this time applying more pressure to remove the 
basement membrane and 10-15 µm of anterior stromal tissue.  See Figure 20 for a schematic of 
this procedure. Immediately after the procedure mice received 3 mg/kg ketoprofen for analgesia. 
Fibrin Gel and LBSC Application 
LBSCs expanded in human serum at 1 x 106 cells/ml in DMEM/F-12 were stained with 50 µg/ml 
Vybrant DiO(3,3’-dioctadecyloxacarbocyanine) (Life Technologies) 20 minutes 37ºC. The cells 
were washed twice with DMEM/F-12 and resuspended in a solution of human fibrinogen, 20 
mg/mL in PBS at 2.5 x 107 cells/ml.  This concentration was determined to be the maximum 
number of cells that was retained on the corneal surface during healing. The relationship between 
cell number and biological efficacy was not investigated. After wounding, 0.5 µL thrombin (100 
U/mL, Sigma) was added to the wound bed followed immediately by 1 µl of fibrinogen (with or 
without LBSCs).  After 1-2 min, the fibrinogen had gelled, a second round of thrombin and 
fibrinogen was added.  The wound was irrigated with sterile PBS and a drop of gentamycin 
ophthalmic solution 0.3% was added.  The corneal epithelium closed the wound in 24-36 hr. 
Immunostaining was performed after 4 weeks, as described above. Eyes were examined daily for 
signs of rejection and infection for 1 week and weekly thereafter.  
Optical Coherence Tomography (OCT) 
OCT was performed weekly to quantify light scatter, the cause of reduced vision in corneal scars 
147,148. Mice were anesthetized by intraperitoneal injection of ketamine (50 mg/kg) and xylazine 
(5 mg/kg) and eyes were scanned using a Bioptigen SD-OCT (Bioptigen, Research Triangle 
Park, NC). Animals were randomized as to order of analysis, and scanning data was collected 
and analyzed in a masked fashion regarding experimental treatment of the animals. Image 
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processing and analysis were conducted using ImageJ (NIH) and MetaMorph 7.7.3 (Molecular 
Devices, Inc). For quantification of corneal light scatter, Imaris (Bitplane USA) was used to 
isolate the cornea from the lens, iris, and interfering eyelashes. Pixel intensity measurements 
were taken both of the cornea and background using ImageJ and exported to Excel (Microsoft 
Corp), where the average background pixel intensity was subtracted from the average corneal 
pixel intensity. For generating threshold images, corneal epithelium was removed using 
Metamorph to isolate only the corneal stroma. Control eyes were used to set the threshold, and 
scar volume beyond the control threshold was displayed graphically.  
Transmission Electron Microscopy 
Three corneas per group were analyzed by transmission electron microscopy. The corneas were 
processed as described previously 106,158. Briefly, tissue was fixed immediately post-mortem in 
fresh 4% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M sodium cacodylate, pH 7.4, and 8 mM 
CaCl2 followed by postfixation with 1% osmium tetraoxide. After dehydration in an ethanol 
series followed by propylene oxide, corneas were infiltrated and embedded in a mixture of 
EMbed 812, Nadic methyl anhydride, dodecenyl succinic anhydride, and DMP-30 (Electron 
Microscopy Sciences). Thin sections were cut using a Leica Ultracut UCT ultramicrotome 
equipped with a diamond knife and were stained with 2% aqueous uranyl acetate and 1% 
phosphotungstic acid, pH 3.2. Anterior and posterior stroma regions of sections from central 
cornea were captured by investigators masked to the experimental treatment of the eyes. 
Micrographs were captured at 80 kV using a JEOL 1400 transmission electron microscope 
(JEOL Ltd) equipped with a Gatan Orius widefield side mount CC Digital camera (Gatan Inc).  
LBSC-treated eyes were fully sectioned and serially screened to confirm the absence of scarring. 
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Statistical analyses   
LBSCs were isolated from 4 separate donor eyes, so data in Figs. 14, 15, 16, and 17 present 
mean values of four biological replicates. P values for differences were determined by double-
sided non-parametric t-tests or ANOVA with Tukey’s post-hoc analysis, as indicated in figure 
captions, using GraphPad Prism software. Differences were considered significant when P<0.05. 
Error bars show standard deviation of the mean unless otherwise indicated in the figure legend. 
Determination of differences in vascularization in Figure 24, shown in Table 6 used the chi 
squared test on a 2 x 2 contingency table to determine 2-tailed P values.  
3.3 RESULTS  
3.3.1 Culture characteristics of limbal biopsy-derived stromal cells 
Cells were obtained from donated human corneas from which a central button had been taken for 
penetrating keratoplasty. Tissue samples were excised in a manner simulating limbal biopsies 
used to obtain epithelial cells from living human patients (Figure 15) 80,159,165,166. In initial trials, 
stromal cells were released by collagenase digestion with or without prior removal of epithelial 
cells using the neutral protease dispase. Previously we found that an initial dispase treatment 
yielded mesenchymal cell cultures free of epithelial cells 89. Isolation of cells using only 
collagenase (omitting dispase) produced primary cultures (Passage 0) cells with both epithelial 
and mesenchymal morphology (Figure 16A). After expansion (Passage 3) cells with epithelial 
morphology were lost and cultures consisted of homogenous small mesenchymal cells (Figure 
16A). Collagenase-only isolation of cells resulted in significantly faster proliferation of LBSC  
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than dispase/collagenase isolation (Figure 16B, Table 3).  
Colony Area FBS HS 
Mean 5.789 7.472 
S.D. 3.15 5.121 
N 415 549 
p value 
(t-test) 
<0.0001  
Table 3 Area of Colonies Cultured in Different Sera 
 Area of colonies from clonogenicity assay (Figure 16) comparing FBS and HS. 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
 
Figure 15 Ex Vivo Model of Corneal Limbal Biopsy 
Donated human corneas were used in this study after removal of central tissue for transplant.  A dissection 
procedure was designed obtain tissue identical to that of an in vivo surface biopsy. (Top left)  The remnants of the 
conjunctiva and Tenon’s capsule (dashed-line) were excised from the corneo-scleral rim using Vannas scissors.  
(Top right) The limbal epithelium (blue dashed-line) was left intact. (Bottom left)   A 1.5 to 2mm wide strip of 
superficial limbal tissue, including the epithelium and a sliver of limbal stroma was excised with the same scissors. 
The area from which the biopsy was obtained is highlighted within the green dashed-lines. (Bottom right) The 
annular biopsied limbal tissue was cut into 8, 1.5 clock-hour segments (black dashed-lines) each the same size as 
obtained from a clinical limbal biopsy procedure. 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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Figure 16 Ex Vivo Expansion and Clonogenecity of Limbal Biopsy Stromal Stem Cells 
(A) Phase-contrast images of primary cells cultured from limbal biopsy tissue prepared by digestion with 
collagenase only. In initial plating (P0), red dashed lines mark islands of epithelial cells. Scale bars, 50 um. (B) The 
length of time (in days) required to expand cells from P0 to P3 was compared to LBSCs prepared with dispase and 
collagenase (DSP + COL) or collagenase only (COL), expanding cells in either HS or FBS. Data are means +/- (n=4). P 
value determined by two-way analysis of variance (ANOVA). (C) Clonal growth of LBSCs in HS and FBS. (D) 
Percentage of clonogenic cells in P3 cultures. Data are means +/- SD (n = 4)). (E) Colony size was calculated with Fiji 
image analysis software. Data are means +/- SD (n > 400). P values in (D) and (E) were determined by a two-sided t test. 
(F) Corneal fibroblasts in FBS did not exhibit clonal growth (n =4). 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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3.3.2 Stem cell–like properties of LBSCs 
Mesenchymal cells isolated from limbal biopsies were highly clonogenic irrespective of the 
culture conditions (Figure 16C). Approximately 40% of passage 3 cells grew as colonies from 
cells expanded in the presence of fetal bovine serum (FBS) or human serum (HS) (Figure 16D, 
Table 2).  Cells cultured in FBS had significantly smaller colonies compared clones in HS 
(Figure 16E, Table 5). Stromal fibroblasts, mesenchymal cells from central cornea, did not form 
colonies under identical conditions (Figure 16F).   When cultured in substratum-free conditions, 
LBSCs organized into free-floating spheres (Figure 17A).  Under these conditions LBSCs 
Figure 17 Sphere Formation and Stem Cell Gene Expression by LBSC 
Passage-3 LBSC were cultured 2 weeks in low-attachment plates in a sphere-forming medium as described 
in Methods.  (A) Cells formed into spheres 100-200 µm in diameter.  (B) Gene expression of characteristic of adult 
and pluripotent stem cells was determined in spheres by qPCR as describe in Methods. Cells expanded in human 
serum (red bars, HS) and fetal bovine serum (blue bars, FBS) showed no significant differences in expression levels. 
Values are an average of values obtained from four different cell line cells obtained from separate donor corneas. 
Error bars represent standard deviation. Scale bar shows 200 µm. 
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upregulated expression of genes associated with both adult and pluripotent stem cells (ABCG2, 
Nestin, OCT4, PAX6, NGFR and SOX2) (Figure 16B).   
3.3.3 LBSCs differentiate into keratocytes in vitro  
LBSCs cultured on a collagen gel substratum in ascorbate-containing, serum-free keratocyte 
differentiation medium (KDM) exhibited a marked decrease in the expression of the stem cell 
genes ABCG2 and Nestin, and an increase in expression of genes associated with keratocyte 
differentiation: ALDH3A1, AQP1, KERA and PTGDS (Figure 18) 130,163,167. When LBSCs were 
cultured on a substratum of parallel, aligned nanofibers 133,153 in KDM, the cells secreted a thick 
ECM of fibrillar collagen type I, and keratan sulfate-containing proteoglycans (Figure 19). The 
cells and collagen fibrils showed strong alignment with the nanofiber substratum, but collagen 
deposited 30-40 µm above the substratum exhibited an orientation rotated by about 40º with 
respect to the lower layers (Fig. 19A). This rotation is similar to that of stromal lamellae in vivo, 
demonstrating a lamellar organization similar to that of corneal stroma. After 30 days in culture 
the collagen construct was 35-40 µm in thickness (Figure 19B), a value independent of the 
culture medium. Conditioned media pooled from cultures contained high molecular weight 
(>130 kDa) keratan sulfate–containing proteoglycans, unique components of corneal ECM 
(Figure 19C). 
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Figure 18 Gene Expressio During Ex Vivo Differentiation of LBSC 
LBSCs expanded to P3 in FBS or HS were cultured in differentiation 
conditions on collagen gels for 1 week. mRNA was quantified as copies per nanogram 
of cellular RNA, determined by quantitative polymerase chain reaction (qPCR). Data 
are averages +/- SD from four different cell lines, each obtained from a different donor 
cornea. P values were determined by two-sided t-test. 
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3.3.4 Human LBSCs engraft in murine cornea in vivo 
The ability of LBSCs to prevent and/or remediate corneal scarring was examined using a mouse 
corneal debridement model which induces fibrotic matrix deposition, long-term disruption of the 
organization of the stromal collagenous ECM structure, and produces visible stromal scars 158.  
Figure 19 Generation of Three-Dimentional Stroma-Like Tissue In Vitro 
ECM produced by LBSCs cultured on aligned nanofiber substrate for 4 weeks was 
imaged by confocal microscopy apturing optical sections at different z levels above the 
substratum. (A) Type I collagen fibrils (green) and keratocytes (nuclei, blue; F-actin, red) are 
shown at different depths of the construct. (B) Thickness of collagenous matrix at 4 weeks in 
HS or FBS was determined from confocal analysis. Data in (B) show averages +/- SD from cell 
lines from four different donors. Lack of significance (NS; P > 0.05) was determined by a two-
sided t test. (C) Cornea-specific keratin sulfate proteoglycan (KSPG) was detected by 
immunoblotting. Alternate lanes show sensitivity of the heterogeneous KSPG band (130 to 300 
kD) to keratanase (KSase). Mr, relative molecular mass. 
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At the time of wounding, 50,000 LBSCs were applied to the wound bed in a solution of 
fibrinogen, which formed a fibrin gel in response to the concomitant addition thrombin. At one 
week after wounding, 3,3’-dioctadecyloxacarbocyanine (DiO)-labeled LBSCs remained in the 
cornea distributed throughout the wounded area (Figures 20 and 21A). LBSCs remained in the 
anterior stroma, for at least four weeks during which time the average number of engrafted cells 
decreased by about half (data not shown). During that time no inflammation or rejection was 
observed in response to these cells. Four weeks after wounding, anterior stromal tissue subjacent 
to the corneal epithelium and near engrafted LBSCs, contained human keratocan and type-I 
collagen, components of normal transparent stromal ECM (Fig. 21B).   
Figure 20 Murine Corneal Debridement Model 
This cartoon shows debridement of the surface of the mouse cornea using an Algerbrush 
II motorized burr.  The debridement continues through the epithelial basement membrane and into 
the anterior 10-15 µm of the stroma.  Immediately after wounding, 0.5 µl of thrombin solution is 
added to the wound surface followed by fibrinogen (1 µl) containing 50,000 LBSC cells.  
Subsequent analysis shows that the corneal epithelium closes the wound engrafting the fibrin-gel 
trapped cells in the anterior stroma.  
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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Figure 21 LBSC Engraftment and Stromal Matrix Synthesis in Mouse Cornea In Vivo 
Fluorescent DiO-labeled human LBSCs were transferred to a superficially debrided mouse cornea in a 
fibrin gel as depicted in Figure 18.  (A) One week after wounding, whole-mount staining showed persistence of 
the human LBSCs (green) in the central cornea. (B) At 1 month, histological sections immunostained with 
human-specific antibodies show human keratocan and collagen type I. Omission of primary antibody controlled 
nonspecific staining. In all images, nuclei are stained with 4’,6-diamidino-2-phenylindole (DAPI) (blue). 
Anterior of the eye is oriented up in each images in (B), and the corneal epithelium is visible as a dense layer of 
cells near the top of each image. Ctrl, control. 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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3.3.5 LBSCs promote regeneration of stromal tissue during wound repair 
Wound repair in the corneal stroma typically results in the accumulation of a number of 
ECM components associated with light-scattering scar tissue, absent in normal stroma, including 
fibronectin, tenascin-c, biglycan, hyaluronan, type III collagen, and SPARC (secreted protein 
acidic and rich in cysteine) 30,31,168-171. In wounds allowed to heal without addition of LBSC 
(Figure 22A, left panels), fibrotic markers hyaluronan, fibronectin, tenascin-c, biglycan, and 
decorin were abundant in anterior stroma, indicating scar formation. In wounded corneas treated 
with LBSCs, only the proteoglycan decorin, a component of normal stromal matrix, was detected 
(Figure 22A). Similarly, mRNAs for mouse type III collagen and SPARC were upregulated two 
weeks after wounding in debrided corneas; however, the presence of LBSCs significantly 
reduced the upregulation to levels similar to unwounded controls (Figure 22B).   
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Low-magnification photos of wounded corneas using diffuse lighting revealed the 
presence of visible scarring in all of the eyes that healed without LBSCs, whereas visible scars 
were absent in all eyes receiving LBSCs (Figure 23A). Light scatter by corneal scars, a cause of 
reduced visual acuity, was assessed using spectral domain optical coherence tomography (OCT). 
Light scatter in individual cross-sectional OCT scans was revealed as bright stromal regions in 
un-treated corneas 2 and 4 weeks after debridement (Figure 23B). Thresholding of these bright 
pixels in en face projections allowed a qualitative assessment of scar area and volume (Figure 
23C). Quantification of the thresholded images revealed a significant increase in light scatter in 
the untreated scars at both 2 weeks and 4 weeks after wounding (Figure 23D). In eyes treated 
with LBSCs at the time of wounding, however, light scatter was not increased compared to the 
pre-operative normal corneas (Figure 23D).  
 Figure 22 LBSC Block Deposition of Fibrotic Matrix in Healing Murine Corneas 
(A) Debridement-wounded mouse corneas were treated with fibrin gel only (no cells) or with 50,00 LBSCs in fibrin gel. 
After 4 weeks of healing, histological sections (epithelium oriented up) were stained for fibrotic markers decorin, 
biglycan, tenascin C, fibronectin, and hyaluronan. Images are representative of sections from three corneas for each 
condition. (B) Quantification of SPARC and Type III Collagen (COL3A1) mRNA preoperative (pre-op) and weeks after 
treatment with LBSCs or no cells. Data are averages +/- SD. P values determined by two-sided t test. 
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Figure 23 LBSC Treatment Influences Light Transmission Properties of ECM Deposited after Debridement 
(A) Macroscopic images of mouse eyes in diffuse lighting reveal opaque scars (arrow) in untreated (no cells) eyes but 
none in LBSC-treated corneas. (B) OCT imaging shows transverse optical sections of preoperative (Pre-op) eyes and those 2 
and 4 weeks after debridement, with scarring visible as bright pixels in the corneal stroma. (C) Thresholding of high-intensity 
pixels in three-dimensional (3D) OCT images of individual corneas defines scarred region (green) at 2 and 4 weeks after 
debridement. (D) Light scatter in 3D OCT scans at 2 and 4 weeks was compare with the values in preoperative eyes. Data are 
means +/- SD. The number of eyes is indicated in the graph. P values were determined with unpaired t tests at each time point 
compared to respective Pre-op values. (E) Transmission electron micrographs 4 weeks after debridement show the ablated 
region of the anterior stroma. Epi, epithelial cells; bm, basement membrane; k, keratocyte processes; L, amorphous matrix 
deposit (lake). Insets show magnification of a box (1um X 1 um) from the indicated region containing orthogonal views of 
collagen fibrils. Scale bar, 2 um. Images are representative of n = 3 animals. 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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Corneal transparency relies on a high level of ultrastructural organization of the 
collagenous ECM of the stroma 26,172. It was therefore important to assess whether LBSC-treated 
eyes showed differences in collagen organization compared to wounds that did not receive stem 
cells. Transmission electron micrography of the healed untreated wounds showed ablated region 
of the anterior stroma to be reconstituted with ECM typical of that of corneal scars (Figure 23E, 
left panel). New ECM lacked characteristic lamellae organization. Collagen fibrils were large 
(inset), typically not tightly packed or in parallel orientation, and the tissue contained amorphous 
deposits and empty regions known as lakes173. In healed corneas treated with LBSCs, collagen 
organization in the stroma was essentially indistinguishable from that of native tissue (Figure 
23E). Collagen was organized into distinct layers (lamellae) containing small, uniform, tightly 
packed fibrils. Keratocyte processes (k) were seen sandwiched between lamellae. Epithelial cells 
(epi) had elaborated a continuous basement membrane (bm).  Higher magnification of the fibrils 
(Figure 23E, insets) showed fibril diameters in LBSC-treated tissue to be significantly smaller 
than those of the untreated scars (31.0+/- 2.9 nm  vs 50.6 +/- 6.6 nm, respectively, P= 0.001 
using a single sample t-test, n=28).  
3.3.6 LBSC treatment reduced corneal vascularization in mice 
Adult cornea is a non-vascularized tissue, and neo-vascularization in response to inflammation or 
trauma can represent a threat to vision. Immunostaining of healed corneas for CD31, a marker of 
vascular endothelial cells, revealed blood vessels in the central region of all (5 of 5) corneas that 
healed without addition of LBSCs (Figure 24A). Conversely, 3 out of 5 corneas that healed with 
LBSC treatment were free of central blood vessels (Figure 24B). Chi-squared analysis of these 
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results demonstrated a significant reduction in the vascularization in response to LBSC treatment 
(Figure 24C). 
 
3.4 DISCUSSION  
Over the past decade we have characterized multipotent mesenchymal stem cells in human 
corneal stroma which differentiate to keratocytes and elaborate a multilamellar collagenous ECM 
resembling that of cornea stroma 89,106,130,133,153,163. In vivo, these cells restore transparency to 
lumican knockout mice, which have hazy stromas and disorganized stromal collagen 106. The 
current study reveals two new properties of these cells. First, these cells can be obtained in a 
biopsy procedure that will permit autologous use. Second, we show that in an actively healing 
Figure 24 Vascularization of Debridement Wounds 
One month after wounding, whole-mount corneas were stained with antibody to CD31 (red) to detect 
ingrowth of blood vessels. Cell nuclei were imaged with DAPI (blue), and added human LBSCs appear green. (A) 
Vessels in a healed cornea in which no cells were added. (B) DiO-labeled LBSCs are visible (green) but no vessels 
were present in the central LBSC-treated wound. (C) A stacked bar graph shows the proportion of vascularized 
corneas in human LBSC-treated (n=5) and untreated (n=5) mouse eyes analyzed by staining as in (A). P value was 
obtained from a two tailed chi-squared test with a 2 X 2 contingency table. 
Basu S*, Hertsenberg AJ, et. al. doi: 10.1126/scitranslmed.3009644 
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wound, these cells suppress accumulation of fibrotic scar tissue and promote regeneration of new 
native, transparent corneal ECM. Together these findings present an argument for investigating 
clinical use of LBSCs to treat corneal scarring.  
Our data demonstrate that corneal stromal stem cells can be obtained from a small surface 
ocular biopsy. In the current study we emulated a biopsy procedure, but clinical use of such 
biopsies to obtain limbal epithelial stem cells is well established 80,159,165. The presence of 
mesenchymal cells in limbal biopsy tissue has been described 92. The current study confirms that 
mesenchymal stem cells obtained from limbal biopsies are functionally equivalent to corneal 
stromal stem cells we have previously described, based on sphere-forming ability (Figure 17), 
gene expression patterns (Figure 18), and the ability to organize stromal ECM in vitro (Figure 
19). The importance of this finding is that we are now able to use a clinically established 
procedure to obtain autologous stem cells with regenerative potential. These cells also grow 
rapidly in human serum, thus allowing production of a fully autologous, xenobiotic-free cell-
based reagent.   
 Recent reports have described mesenchymal stromal cells proximal to the epithelial 
basement membrane in limbal regions near epithelial stem cells. These mesenchymal ‘niche 
cells’ are thought to help maintain the phenotype of limbal epithelial stem cells in vivo 101,174,175. 
Niche cells can form spheres in vitro and express stem cell genes including ABCG2, SOX2, 
Nanog, OCT4 and Nestin 90,156,175,176.  LBSCs isolated in this study from human limbal biopsies 
closely resembled niche cells. They grew more rapidly when only collagenase was used in their 
isolation and they were highly clonogenic, formed spheres and expressed genes characteristic of 
both adult and pluripotent cells. By these criteria, LBSCs, corneal stromal stem cells, and limbal 
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niche cells appear indistinguishable and probably represent the same population of neural crest–
derived mesenchymal stem cells. 
An important advance contributed by this study is observation that LBSCs induce 
deposition of a native stromal tissue rather than scar tissue in healing wounds. Previous in vivo 
studies have used lumican-null mice, which develop stromal haze owing to abnormal collagen 
fibrillogenesis 106,154. Although the disruption of stromal matrix in these mice resembles that in 
scars, it is not evident that restoration of transparency to lumican null corneas is fully analogous 
to remediation of corneal scars. In the current study we found that human LBSCs in the healing 
wound allowed regeneration of a fully transparent native stromal tissue. The new tissue had no 
expression of fibrotic mRNA or proteins, had no change in light scatter, and had highly 
organized stromal ECM indistinguishable from that of normal mouse cornea. Few mammalian 
tissues heal by regenerating native tissue. Scarring provides a strong and rapid structural repair, 
but tissue functionality can be impaired by scar tissue. This is particularly true for cornea in 
which collagen fibril diameter, parallel alignment, packing, and lamellar organization are 
essential for vision. Traumatic damage to stroma typically heals leaving scar tissue with 
disorganized collagen that scatters light and produces long-term disruption of vision. The ability 
of LBSCs to induce the replacement of ablated tissue with transparent ECM containing native 
components with collagen organization indistinguishable from that of normal stroma is an 
exciting finding that points to the clear potential for use of these cells in clinical applications to 
treat human corneal scars.  
In this study, LBSCs were engrafted only in the most anterior portion of the stroma and 
were in low abundance in comparison to the mouse stromal cells. Amelioration of fibrotic 
matrix, light scatter, and disruption of the stromal organization occurred both where LBSCs were 
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located, and also in more posterior regions of the stoma. The lack of co-localization of LBSCs 
and scarring suggests that LBSCs exert their effects indirectly. Rather than simply replacing 
mouse stromal ECM with that produced by the differentiated LBSC, these cells are likely 
exerting a paracrine influence on the mouse stromal cells repopulating the wounded region. The 
mechanism of this regenerative effect is unknown. The ability of the stem cells to work at a 
distance may be an advantage in cell-based therapy of existing scars, in that it may not be 
necessary to saturate scar tissue with stem cells but rather only to deliver them proximal to the 
region needing to be regeneration. Whether existing scars can be treated with these cells remains 
an open question.  
Much work over the previous decade has focused on corneal limbal epithelial stem cells 
for treatment of limbal stem cell deficiency, a potentially blinding, but rare condition. 
Autologous limbal epithelial stem cells have been successfully used to correct this condition in 
several human trials 78,80,159-161,177. Corneal epithelium and stroma are structurally and 
functionally distinct tissues, and epithelial stem cells are not suitable for stromal therapy. 
However, the positive results of pioneering clinical trials with epithelial stem cells, and the data 
presented in our current study strongly support the idea that autologous mesenchymal stem cells 
(LBSCs) may be successful in treating stromal scarring, the major cause of corneal blindness in 
the world. Because these cells can be obtained and cultured in an autologous, xenobiotic-free 
fashion, and because fibrinogen-based adhesives are currently approved for ocular applications, 
barriers to bringing this treatment to clinical trial may be modest.  
In summary, we have found a population of mesenchymal cells expanded from human 
limbal biopsy tissue with the potential to differentiate into keratocytes, to generate stromal tissue 
in vitro, to block corneal scarring, and to stimulate regeneration of transparent stromal tissue in 
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murine healing wounds in vivo. The ability to obtain cells from clinically reliable biopsies and to 
expand them in human serum presents the opportunity to use these cells clinically to remediate 
cornea wounds and scars.  
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4.0  NEUTROPHIL REDUCTION PREVENTS CORNEAL LIGHT SCATTER:               
A POTENTIAL MECHANISM FOR LBSC IN WOUND HEALING 
4.1 INTRODUCTION 
Vision impairment and blindness are devastating conditions affecting millions of people 
worldwide. Corneal blindness – the result of scarring that occurs after ocular trauma or infection 
– affects 7-10 million people globally178. Currently the only treatment option for these patients is 
corneal transplant (penetrating keratoplasty), a procedure complicated by tissue rejection and 
limited by the supply of donor tissue179. As such, there is an increasingly important need to 
develop alternative therapies for these patients. 
Alternatives to cadaveric transplant for penetrating keratoplasty, including prostheses, 
cell therapy, and bioengineered tissues are currently being studied with the hope of becoming 
standard of care for corneal scars. Indeed, collagen based prosthetics for corneal transplants are 
being developed and have been successful as corneal grafts in animals 180-182.  Stem cells are also 
being investigated for use as cell therapy as well as for the engineering of biosynthetic graft 
tissue. Human corneal stromal stem cells (hCSSC) are of particular interest as the natural 
progenitor for the cells that make up the corneal stroma.  hCSSC have successfully been isolated 
and from human limbal tissue, were demonstrated to produce stroma-like tissue, and shown to 
restore transparency in a genetic model of corneal haze in mice 89,106,130. These same cells have 
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also been used to generate organized, collagenous matrices that mimic corneal tissue that may be 
useful as a biosynthetic prosthetic for transplant 133,153,183. More recently, we have shown that 
limbal biopsy-derived hCSSC prevent fibrotic wound healing that causes scarring and promote 
regeneration in a mouse model of corneal wounding 107.  This finding may lead to the use of 
hCSSC in an autologous manner to repair damaged corneal tissue in a way that avoids the use of 
donor tissue. Key to moving forward with hCSSC cell therapy is to elucidate the mechanism by 
which they prevent fibrosis and scarring.  
Stem cells offer the ability to regenerate damaged tissue with both function and integrity. 
A multitude of studies have revealed these characteristics in multiple wound models 184-187. It is 
becoming increasingly apparent that immunomodulation by stem cells is largely responsible for 
anti-fibrotic/pro-regenerative wound healing where they are applied 188-190. While many secreted 
molecules are being investigated for immunosuppressive properties, notable among them is 
tumor necrosis factor alpha stimulated gene 6 (TSG-6) 191-193. TSG-6 is a matrikine known to 
bind hyaluronan and other glycosaminoglycans, and is expressed by several cell types in 
response to inflammation 194. More specifically, it directly inhibits neutrophil migration by 
binding the chemokine Interleukin-8, a neutrophil chemotactic factor 195. As neutrophils are the 
first responders to wound sites and function in part by recruiting other inflammatory cells, it 
stands to reason that preventing their infiltration at the site of injury may prevent tissue-
damaging effects of later arriving cells such as macrophages. Indeed, TSG-6 added topically or 
via secretion by bone marrow derived mesenchymal stem cells has been shown to modulate 
wound healing by preventing the acute phase of inflammation 196-198.   
In the present study, we investigated the mechanism by which hCSSC derived from 
limbal biopsies (termed LBSC) prevent fibrosis in a mouse model of corneal wounding described 
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in previous studies 107,158. We hypothesize that LBSC, like other mesenchymal stem cells, have 
immunomodulatory properties that abrogate fibrotic wound healing. We show for the first time 
that LBSC produce TSG-6, that the expression of this protein reduces neutrophil infiltration to 
the corneal stroma after wounding, and that this leads to the reduction of light scatter observed in 
LBSC treated wounds. In contrast to previous studies that examined short-lived stromal haze in 
acute wounds shortly after injury, the present study follows wounds for four weeks to assess light 
scatter as a result of clinically relevant fibrotic scarring. Our results add to the collection of 
literature demonstrating the importance of TSG-6 in immunomodulation while further 
demonstrating the wound healing capacity of LBSC. 
4.2 MATERIALS AND METHODS 
Limbal biopsy and cell culture 
Human corneo-scleral rims from donors younger than 60 years with less than 5 days of 
preservation were obtained from the Center for Organ Recovery and Education (www.core.org). 
Research followed the tenets of the Declaration of Helsinki, de-identified living donors approved 
tissue for research purposes, and the research approved by the institutional review board (IRB). 
Limbal biopsies were performed as described previously107. Briefly, rims were rinsed in 
Dulbecco’s modified Eagle’s medium (DMEM/F12) with antibiotics. Corneal conjunctiva was 
grasped with a toothed forceps and subconjunctival dissection was carried out with Vannas 
scissors toward the anatomical limbus 0.5 mm into the cornea. Conjunctiva was excised, and 
dissection of anterior limbal tissue was carried out circumferentially in the same plane. An 
annular ring of tissue consisting of the superficial limbal epithelium and stroma was excised.  
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Excised limbal segments were incubated in collagenase (0.5 mg/ml) (Sigma-Aldrich, type 
L) overnight at 37°C. The next day, digests were triturated, incubated for an additional hour, and 
filtered through a 70-μm, nylon filter to obtain a single-cell suspension. Cells obtained from each 
segment were seeded onto FNC (AthenaES)–coated wells of a 12-well tissue culture plate in 
stem cell growth medium106 (“SGM”) containing 2% (v/v) pooled human serum (Innovative 
Research). Culture medium was changed every other day and cells were passaged by brief 
digestion with TrypLE Express (Life Technologies) when 80% confluent into six-well plates, 
25-cm2 T-flasks, and 175-cm2 T-flasks at P1, P2, and P3, respectively. For tsg-6 expression 
studies, LBSC were cultured in SGM with 15 ng/mL TNFα for up to 72 hours. Differentiation 
conditions were as described previously153 in keratocyte differentiation medium (“KDM”) 
composed of advanced DMEM (containing GlutaMAX, Gibco, 12491), ascorbate-2-
phosphate (1 mM), fibroblast growth factor–2 (10 ng/ml), and transforming growth factor–
β3 (0.1 ng/ml). 
siRNA Knockdown 
Five hundred pmoles of TSG-6 siRNA (Santa Cruz Biotechnologies) in 50 µl serum and 
antibiotic free OptiMEM (Life Technologies) was mixed with 100 µl of OptiMEM containing 4 
µl Lipofectamine 2000 (Life Technologies) pre-incubated 20 min at room temperature.   5x 105 
LBSC in 0.4 ml of antibiotic-free Advanced-MEM (Life Technologies) were added to the siRNA 
and incubated for 3 hr on a rocking platform at 37 ºC. The cell suspension was washed 3 times to 
remove lipofectamine and plated in SGM.  As a control, cells were transfected with scrambled 
siRNA.  Cells were cultured at 37 ºC with 5% CO2 for 48 hours before being suspended in 
fibrinogen as described next. 
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Fibrin gel and LBSC application 
Five hundred thousand LBSC were suspended in a solution of human fibrinogen, 20 mg/ml in 
PBS at 2.5 × 107 cells/ml. After wounding, 0.5 μl of thrombin (100 U/ml, Sigma) was added to 
the wound bed, followed immediately by 1 μl of fibrinogen (with or without LBSC treated with 
siSCR or siTSG-6). After 1 to 2 min, a fibrin gel formed, and a second round of thrombin and 
fibrinogen was applied. The wound was irrigated with sterile PBS, and a drop of gentamicin 
ophthalmic solution (0.3%) was added. The corneal epithelium reformed over the wound in 24 to 
36 hours. Immunostaining was performed after 4 weeks, as described above. Eyes were 
examined daily for signs of rejection and infection for 1 week and weekly thereafter. 
Corneal debridement 
All animal procedures were done in accordance with The Association for Research in Vision and 
Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and 
approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. 
Debridement procedures were done as previously described 107,158. Briefly, 7-week-old female 
C57BL/6 mice in groups of 5 were anesthetized by intraperitoneal injection of ketamine (50 
mg/kg) and xylazine (5 mg/kg). Our previous study and power analysis determined that at least 
six eyes were required for statistical significance in optical coherence tomography (OCT) 
analysis and that 2 and 4 weeks provided appropriate time points for analysis of gene expression 
and fibrosis 107,158. One drop of proparacaine hydrochloride (0.5%) was added to each eye before 
debridement for topical anesthesia. Corneal epithelial debridement was performed by passing an 
AlgerBrush II (The Alger Company) over the central 2 mm of the mouse cornea. Once the 
epithelium was removed, a second application of the AlgerBrush II was used, this time applying 
more pressure to remove the basement membrane and 10 to 15 μm of anterior stromal tissue. 
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Immediately after the procedure mice received Ketoprofen (3 mg/kg) for analgesia. 
Neutralizing Antibody 
Three female C57Bl/6 mice at 8 weeks of age were used per group (with or without antibody). 
24 hours prior to debridement, 0.5 mg of the anti-Ly6G (clone 1A8) neutropenia-inducing 
antibody was given via intraperitoneal injection. A second dose was given at the time of 
debridement. Corneas were wounded as described above with no cells added.  
Flow Cytometry for Neutrophil Quantification 
24 hours after wounding, mice were sacrificed and both eyes were enucleated and the corneas 
dissected. Corneas were cut into quarters and digested in Collagenase Type 1 (Sigma) 820 U/mL 
in DMEM/F12 + 10% fetal bovine serum (FBS) at 37ºC for 1 hour, vortexing every 20 minutes 
to break up tissue. Digests were then triturated until tissue was completely broken up and 
digested for 20 minutes longer if necessary. Digests were then filtered through 70-μm nylon filter 
to remove debris. Cell suspensions were then pelleted by spinning at 340 x g for 10 minutes and 
pellets resuspended in 50μL staining buffer: phosphate buffered saline, 1% FBS, and 0.1% 
sodium azide. Keeping the cells on ice, Fc-Block, CD45-PerCP, Gr-1-PE (clone RB6-8C5), and 
CD11B-AF647 (all BD Biosciences) were added at 1:50 and incubated for 30 minutes on ice in 
the dark. Cells were then washed in 1mL of staining buffer and resuspended in 300uL 1% PFA 
in staining buffer before being run on a FACS Aria III Flow Cytometer (BD Biosciences). Data 
were analyzed using FlowJo 8.7 (FlowJo) and statistical analysis calculated using Prism 6 
(GraphPad).  
Real Time Polymerase Chain Reaction (RT-qPCR) 
RNA isolated by Qiagen Miniprep was transcribed to cDNA using SuperScript III (Life 
Technologies). cDNA and target primers (Table 4) were combined with SYBR Green Real-Time 
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Master Mix (Life Technologies) and real-time polymerase chain reaction run and data analyzed 
using the StepOnePlus Real-Time PCR System (Applied Biosystems). 
 
Table 4 Target Primers Used for qPCR 
 
Immunostaining 
Immunostaining of mouse tissue was carried out on 8-μm cryostat sections fixed in ice-cold 4% 
paraformaldehyde, 70% ethanol, and 5% glacial acetic acid (v/v) for 10 minutes and blocked 
with 10% heat-inactivated goat or donkey serum in phosphate-buffered saline (PBS). A human 
specific antibody to TSG-6 (1:150, Santa Cruz Biotechnology) was incubated on the sections at 
4°C overnight. Slides were then washed three times in PBS and stained with AlexaFluor 546–
conjugated anti-rat secondary antibody (Life Technologies) at 1:1000 for 2 hours at room 
temperature. Slides were subsequently washed three times in PBS before staining with DAPI for 
15 minutes at room temperature. Slides were imaged with an Olympus FluoView 1000 confocal 
microscope with a 20X or 40X oil objective. 
 
Spectral Domain Optical coherence tomography 
OCT and analysis were performed as described previously107,158. Briefly, OCT was used 4 weeks 
after injury to quantify light scatter, the cause of reduced vision in corneal scars147,148. Mice were 
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anesthetized by intraperitoneal injection of ketamine (50 mg/kg) and xylazine (5 mg/kg), and 
eyes were scanned with a Bioptigen SD-OCT (Bioptigen). Animals were randomized as to order 
of analysis, and scanning data were collected and analyzed in a masked fashion regarding 
experimental treatment of the animals. Image processing and analysis were conducted with 
ImageJ [National Institutes of Health (NIH)] and MetaMorph 7.7.3 (Molecular Devices Inc.). For 
quantification of corneal light scatter, Imaris (Bitplane USA) was used to isolate the cornea from 
the lens, iris, and interfering eyelashes. Pixel intensity measurements were taken both of the 
cornea and of the background with ImageJ and exported to Excel (Microsoft Corp.), where the 
average background pixel intensity was subtracted from the average corneal pixel intensity.  
4.3 RESULTS 
4.3.1 LBSC express tsg-6 after TNFα stimulation and during differentiation. 
TSG-6 is a hyaluronan binding protein whose expression is induced by tumor necrosis factor 
alpha (TNFα) 199. It is expressed by a multitude of cell types, notably stem cells. As it has not yet 
been shown to be expressed by corneal stromal stem cells, we first tested if LBSC did indeed 
express Tsg-6. After treatment with TNFα, LBSC increased expression of Tsg-6 nearly 3-fold 
after both 24 and 72 hours in culture as measured by quantitative PCR (Figure 25A). While 
it is an important finding that LBSC express Tsg-6 after TNFα stimulation, we also wanted 
to examine whether tsg-6 expression would increase as the cells differentiate. After 72 
hours in differentiation medium (with no exogenous TNFα added), Tsg-6 expression is 
upregulated nearly 50-fold compared to undifferentiated cells (Figure 25B). To be sure the 
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cells were differentiating, we also looked at the expression of Keratocan, a marker of hCSSC 
differentiation 200,201. Indeed, Keratocan expression was significantly upregulated 
compared to control cells. These results demonstrate that human corneal stromal stem 
cells express tsg-6 both after TNFα stimulation as well as during the differentiation process.  
 
 
 
 
 
 
Figure 25 LBSC Express Tsg-6 upon TNF-alpha Stimulation and During Differentiation 
A) Tsg-6 expression is significantly upregulated 24 and 72 hours after culture with TNFα.  
B) Tsg-6 expression is significantly upregulated (p<0.001) 72 hours after culture in keratocyte 
differentiation medium (KDM). Kera was used as a positive control for differentiation and expression 
was significantly upregulated (P<0.01), confirming differentiation. ANOVA with Dunnett’s post-test. 
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4.3.2 LBSC produce TSG-6 in mouse corneal stromal wounds. 
Our previous study examining the ability of LBSC to prevent fibrosis in mouse corneal wounds 
demonstrated a model wherein successful engraftment of LBSC in the corneal stroma is achieved 
after epithelial and partial debridement 107. After showing that LBSC express tsg-6 in vitro, we 
looked at TSG-6 expression in vivo. Four weeks after wounding, mouse corneal sections were 
stained for TSG-6 using a human specific antibody as described in methods. 
Immunohistochemistry shows that TSG-6 expression in corneas treated with LBSC but no 
expression in controls (Figure 26).  
 
TSG-6 TSG-6 
Figure 26 LBSC Express TSG-6 In Vivo 
4 weeks after wounding, LBSC treated wounds (+LBSC) show TSG-6 expression while untreated wounds  
(-LBSC) do not. 
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4.3.3 LBSC significantly reduce neutrophil infiltration at the wound site via TSG-6. 
TSG-6 has recently been shown in vitro to inhibit neutrophil migration via its interaction with 
Interleukin 8 195.  After demonstrating that LBSC produce TSG-6 in vivo, we tested the effect of 
LBSC treated with and without siRNA to tsg-6 on neutrophil infiltration at the cornea 24 hours 
after wounding. siRNA to Tsg-6 significantly reduced expression when compared to LBSC 
treated with scrambled siRNA (Figure 27A). LBSC treated with the scrambled siRNA had 
significantly fewer neutrophils present at the wound while LBSC treated with siRNA to Tsg-6 
had nearly the same number of neutrophils as the gel-only control (Figure 27B). 
 
A B 
Figure 27 Tsg-6 Expression by LBSC Reduces Neutrophil  Infiltration to Corneal Wounds 
A) TSG-6 expression is significantly reduced in LBSC treated with siRNA to TSG-6 (siTSG6) when compared to 
LBSC treated with scrambled siRNA (siSCR).  
B) TSG-6 expression by LBSC (siSCR) reduces neutrophil infiltration to the cornea 4 weeks after wounding. 
Statistcal analysis using ANOVA with Tukey’s correction for multiple comparisons. 
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4.3.4 LBSC Reduce Corneal Light Scatter After Wounding via TSG-6 Production. 
The clinical outcome of corneal scarring is vision impairing light scatter that results from the 
scar. When fibrotic matrix replaces the normal, functional matrix of the cornea, light is unable to 
focus properly onto the retina, resulting in vision impairment 26. We assessed light scatter by 
optical coherence tomography (OCT) as in previous studies 107,158. We found that, in corneas 
treated with fibrin gel alone or siRNA to Tsg-6, light scatter as measured by pixel intensity was 
significantly greater than the unwounded mouse; corneas treated with scrambled siRNA did not 
show significantly greater light scatter when compared to the unwounded control (Figure 28).  
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4.3.5 Induction of Neutropenia at the Time of Wounding Prevents Light Scatter 4 Weeks 
After Wounding. 
Because our knockdown of Tsg-6 was relatively inefficient (~40%, Figure 27A) and the dose-
response for TSG-6 on in vivo neutrophil infiltration is unknown, we used a mouse model of 
neutropenia to study the effect that complete abrogation of neutrophils would have on light 
scatter. We used the well-documented neutralizing antibody to Ly6G (clone 1A8) to induce acute 
neutropenia in mice that were wounded 202-205. Flow analysis revealed that the antibody reduced 
the neutrophil population (GR-1+CD11b+) in the cornea 24 hours after wounding from 11.3% to 
roughly 0.25% of the total cell population (Figure 29A). Interestingly, light scatter analysis 
revealed a significant increase in the gel only group when compared to the unwounded mouse 
Figure 28 Tsg-6 Knockdown in LBSC Results in Significantly Greater Light Scatter as Measured 
by OCT Imaging Compared to Unwounded Animals 
   Compared to the unwounded eye, only gel-treated and LBSC+siTSG6 
   treated corneas show significantly increased light scatter 4 weeks after 
   wounding. Statistical Analysis was performed using ANOVA with Dunnett’s post-test. 
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while the antibody treated mouse showed only slightly greater light scatter (but not significantly) 
when compared to the unwounded mouse (Figure 29B). These data support the hypothesis that 
neutrophil involvement in corneal wounds is indeed important to the clinical outcome associated 
with corneal scarring. 
 
 
 
 
A B 
Figure 29 Neutrophil Depletion Prevents Light Scatter After Corneal Wounding 
(A) Flow Cytometry demonstrating neutrophil depletion in the cornea 24 hours after wounding and treatment with a 
neutropenia 
inducing antibody (as described in the Methods section). Antibody clones used for treatment and flow cytometry were 
different.  
       (B)  OCT analysis 4 weeks after wounding and neutropenic-antibody treatment shows that early induction of temporary 
neutropenia prevents the development of corneal light scatter. Statistical analysis: ANOVA with Dunnett’s post-test. 
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4.4 DISCUSSION 
Corneal wounds that result in scarring has caused life-changing vision impairment and even 
blindness in millions of individuals around the world. Due to the lack of available donor tissue 
and complications that arise from transplant therapy, new alternatives are being developed to 
restore vision or prevent scarring in those who suffer corneal blindness. Stem cell therapy offers 
enormous potential in achieving this goal, but the mechanism by which they act is still being 
investigated. 
The present study investigates the mechanism of limbal biopsy-derived corneal stromal 
stem cells as it relates to the expression of TSG-6, a known mediator of neutrophil migration. As 
inflammation at the site of injury often leads to fibrosis, it stands to reason that a dampening of 
the acute response might prevent the fibrotic response. This study demonstrates for the first time 
the LBSC express Tsg-6 upon TNFα stimulation as well as during differentiation – suggesting a 
role for this protein in corneal physiology. That LBSC produce TSG-6 during differentiation 
suggests that as mature keratocytes they may express the protein if stimulated in vivo, a study 
that will be carried out in the future. Additionally, LBSC were shown to produce TSG-6 at the 
site of wounding in a mouse model of corneal fibrosis. That the protein is present at the site of 
injury when LBSC are present suggests that neutrophil infiltration into the stroma may be 
inhibited in these animals, preventing a large, pro-fibrotic inflammatory response to injury.  
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In vivo studies in this study demonstrate the importance of TSG-6 production by LBSC at 
the site of injury in the corneal stroma. siRNA knockdown of Tsg-6 of only 40% resulted in the 
significant reduction of neutrophils in the stroma 24 hours after wounding. Future studies with 
complete TSG-6 knockdown or even knockout will be completed to assess whether or not there 
is a dose response with varying levels of expression. When light scatter was analyzed among the 
treatment groups in this study, it was demonstrated that the gel only controls and wounds treated 
with LBSC + siTSG6 showed significantly greater light scatter compared to the unwounded 
mouse. That the knockdown efficiency was ~40%, and that TSG-6 is known to prevent 
neutrophil chemotaxis, suggests that complete abrogation of the neutrophil response at the site of 
injury may prevent wound healing that results in stromal light scatter. To demonstrate this, the 
neutropenia-inducing antibody to Ly6G was administered to the mouse at the time of wounding, 
light scatter was nearly identical to that of the unwounded animal.  
Interestingly, and in contrast with our previous study examining LBSC 107, the light 
scatter in mouse corneas treated with scrambled siRNA (i.e. LBSC with normal Tsg-6 
expression) was elevated (though not significant when compared to the unwounded eye). We 
believe this is due to the well-documented heterogeneity between donors in isolated stem cell 
populations. This supports the idea that not all donors are equal and stem cells from different 
donors must be characterized – whether it be by stem cell markers, differentiation ability, 
immunomodulatory properties, et cetera - to identify ideal donor candidates.  While we are 
currently undertaking this process for LBSC, other groups have already started the process in 
bone marrow derived mesenchymal stem cells 206.  
Though this study demonstrates that TSG-6 and neutrophils are playing an important role 
in the outcome of corneal wound healing, future studies will examine other inflammatory cells, 
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notably macrophages, for the interaction they may have with stem cells during the wound 
healing process. Stem cells clearly show promise as an alternative treatment to corneal transplant 
for the treatment of corneal scarring. Future studies that further elucidate the mechanism by 
which they function in vivo are needed to further demonstrate their efficacy and justify clinical 
trials for this alternative therapy that may restore vision to millions of people around the world. 
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5.0  SUMMARY AND FUTURE DIRECTIONS 
The goal of the work presented here is to expand the treatment options available to the 
millions of people worldwide suffering from corneal blindness. While corneal transplant is a 
generally successful procedure used to treat this condition, immunological rejection and donor 
tissue shortages necessitate therapeutic alternatives. I have presented data in the preceding 
chapters that lay the groundwork for therapies that may circumvent these complications of 
corneal transplant.  
The data presented here expands what is known about human embryonic stem cells and 
their differentiation capabilities. Until now, it has not been shown that embryonic stem cells are 
capable of differentiating to keratocytes and these results suggest that there may be a cell source 
for corneal tissue engineering and perhaps cell therapy. The demonstration that corneal stromal 
stem cells can be isolated as a biopsy and used to prevent fibrosis has expanded our current 
knowledge of this stem cell population and provided a clinical method for the use of the cells in 
patients in the near future. Finally, studies examining the role of TSG-6 at the site of injury upon 
stem cell treatment and the effect of neutrophil ablation during wound healing expand our 
knowledge of immunomodulation and the role of the immune system after wounding in the 
corneal stroma. 
Human Embryonic Stem Cells (hESC) represent a virtually unlimited source of stem cells 
with the capability to differentiate into corneal keratocytes. In Chapter 2 I describe a two-step 
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method for the differentiation of hESC to keratocytes via a neural crest stem cell intermediate. 
As hESC can be expanded for 100+ passages while retaining stem cell phenotype, they have the 
potential to bridge the gap between supply and demand that exists between patients in need of 
transplant and available donor grafts. Though hESC are not an autologous source of tissue and 
therefore may result in immunological rejection, numerous studies have suggested their 
immunomodulatory properties may prevent such an outcome 207-209. 
Future studies in the lab are aimed at using these cells in mouse models of corneal 
wounding, much like what was presented in Chapter 3. Ideally it will be shown that they act 
similarly or better than the autologous stem cells that were used in that study, supporting the 
hypothesis that these cells are a readily expandable source of cells for therapy. 
Limbal Biopsy-Derived Corneal Stromal Stem Cells (LBSC) are a potential source of 
autologous progenitor cells to corneal keratocytes that actually prevent scar formation in mouse 
corneal wounds, as shown in Chapter 3. In this study we demonstrate that LBSC effectively 
prevent fibrotic wound healing in a mouse model of corneal fibrosis. Though this is a 
preventative measure, as opposed to a treatment for existing scars, the data collected from this 
study will undoubtedly lead to better understanding of these cells which may result in the 
development of therapies via tissue engineering or cell-based tissue replacement. Currenly, Drs. 
Virender Sangwan and Sayan Basu of the L V Prasad Eye Institute (Hyderabad, India) are 
conducting a Phase I clinical trial based on this study to assess the safety of these cells as an 
autologous therapy for the treatment of existing scars. 
Finally, in Chapter 4, I present data that supports the hypothesis that immunomodulation 
by way of blocking neutrophil infiltration to the wound bed may prevent fibrosis after corneal 
wounding. We investigated the protein TNFα-stimulated-gene-6 (TSG-6) for it’s 
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immunomodulatory properties – specifically it’s ability to prevent neutrophil migration to the 
site of wounding 195. Numerous other authors studying mesenchymal stem cells in wound healing 
have also begun investigating this protein and its immunomodulatory and anti-fibrotic action 
191,210-212. We found that LBSC inhibit neutrophil infiltration to the wound site via in the cornea 
via TSG-6 expression after wounding and that a reduction in neutrophil infiltration to the site of 
injury prevents light scatter four weeks after wounding. As such, TSG-6 may be a mechanism by 
which LBSC prevent fibrotic wound healing after injury and, therefore, may be a novel 
therapeutic for the treatment of inflammation after injury. 
Interestingly, and an important aside to mention, in this study we discovered that there 
exist differences between donors in their ability to promote regeneration of corneal tissue after 
wounding. Multiple experiments using LBSC derived from different donors showed enormous 
variability in the ability of these cells to prevent light scatter after wounding. In Figure 28, LBSC 
(treated with scrambled siRNA) fail to prevent light scatter to the same degree that was seen in 
Figure 23 – the only difference between the studies being the patients from whom these donor 
cells were derived. This discovery has resulted in a study wherein different donors are being 
screened via qPCR and neutrophil migration assays to select the donors most likely to suppress 
neutrophil migration and, presumably, reduce light scatter after wounding. While this finding 
was a setback in our study, this knowledge is beneficial to any lab studying cells derived from a 
variety of donors – one donor is not equal to the next. With enough samples, we expect we may 
eventually find a combination of factors (e.g. age, gender, body mass index, underlying illnesses, 
antigen exposure, ad infinitum…) that, together, identify “good” from “bad” donors. 
Stem cell biology is an important field of biomedical research from which numerous 
therapies may one day be derived – expanding the ever-growing field of “personalized” 
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medicine. The data presented in this dissertation add to an expanding body of work in 
ophthalmology, wound healing, and regenerative medicine that aim to provide therapeutic 
alternatives for the treatment of corneal blindness and vision impairment. Progress toward this 
goal will improve the quality of life of millions of people around the globe while what is learned 
during this endeavor informs and improves research in regenerative medicine across all medical 
disciplines. 
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APPENDIX A 
Acronym Definition 
ABCB5 ATP-Binding Casette Sub-Family B Member 5 
ABCG2 ATP-Binding Casette Sub-Family G Member 2 
ALDH3A1 aldehyde dehydrogenase 3 family, member A1 
AQP1 Aquaporin 1 
ATP Adenosine Triphosphate 
B3GNT7 Beta-1,3-N-Acetylglucosaminyltransferase 7 
BM Bowman’s Membrane 
BMI1 Polycomb group RING finger protein 4 (a.k.a. PCGF4) 
C-EBP-Delta CCAAT/enhancer-binding protein delta 
CD271 Cluster of Differentiation 271 (a.k.a. NGFR, p75NTR) 
cDNA Complimentary DNA 
CHST6 Carbohydrate sulfotransferase 6 
CK Cytokeratin 
cKit tyrosine-protein kinase Kit 
DiO 3,3'-Dioctadecyloxacarbocyanine 
DM Descemet’s Membrane 
DNA Deoxyribonucleic Acid 
ECM Extracellular Matrix 
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FACS Fluorescence-Activated Cell Sorting 
FBS Fetal Bovine Serum 
FOXC2 Forkhead box protein C2 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GR-1 Granulocyte Differentiation Antigen 1 
HABP Hyaluronic Acid Binding Protein 
hCSSC Human Corneal Stromal Stem Cell 
hESC Human Embryonic Stem Cell 
HS Pooled Human Serum 
KDM Keratocyte Differentiation Medium 
KERA Keratoan 
KS Keratan Sulfate 
KSPG Keratan Sulfate Proteoglycan 
LBSC Limbal Biopsy-Derived Corneal Stromal Stem Cell 
LESC Limbal Epithelial Stem Cell 
LGR5 Leucine-rich repeat-containing G-protein coupled receptor 5 
LSCD Limbal Epithelial Stem Cell Deficiency 
Ly6G lymphocyte antigen 6 complex, locus G 
MACS Magnetic Activated Cell Sorting 
mRNA Messenger Ribonucleic Acid 
MSX1 Msh homeobox 1 
NC Neural Crest 
NGFR Nerve Growth Factor Receptor (a.k.a. p75NTR, CD271) 
NTRK3 Neurotrophic tyrosine kinase, receptor, type 3 
OCT Optical Coherence Tomography 
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Pax6 Paired box protein Pax-6 
PTGDS prostaglandin D2 synthase 
qPCR 
Real-Time Quantitative Reverse Transcription 
Polymerase Chain Reaction 
SGM Stem Cell Growth Medium 
siRNA Small Interfering RNA 
Six2 SIX homeobox 2 
SNAI1 Snail Family Zinc Finger 1 
SOX9 Transcription factor SOX-9 
SPARC 
Secreted Protein Acidic and Rich in Cysteine 
(a.k.a Osteonectin) 
ßGal Beta-Galactosidase 
TBP1 TATA-box-binding protein 1 
TEM Transmission Electron Microscopy 
TSG-6 Tumor necrosis factor stimulated gene 6 protein 
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